A	O
lymphoid	B-protein
cell-specific	I-protein
nuclear	I-protein
factor	I-protein
containing	O
c-Rel-like	B-protein
proteins	I-protein
preferentially	O
interacts	O
with	O
interleukin-6	B-DNA
kappa	I-DNA
B-related	I-DNA
motifs	I-DNA
whose	O
activities	O
are	O
repressed	O
in	O
lymphoid	B-cell_type
cells	I-cell_type
.	O

The	O
proto-oncoprotein	B-protein
c-Rel	I-protein
is	O
a	O
member	O
of	O
the	O
nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
transcription	I-protein
factor	I-protein
family	I-protein
,	O
which	O
includes	O
the	O
p50	B-protein
and	O
p65	B-protein
subunits	I-protein
of	O
nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
.	O

We	O
show	O
here	O
that	O
c-Rel	B-protein
binds	O
to	O
kappa	B-DNA
B	I-DNA
sites	I-DNA
as	O
homodimers	B-protein
as	O
well	O
as	O
heterodimers	B-protein
with	O
p50	B-protein
.	O

These	O
homodimers	B-protein
and	O
heterodimers	B-protein
show	O
distinct	O
DNA-binding	O
specificities	O
and	O
affinities	O
for	O
various	O
kappa	B-DNA
B	I-DNA
motifs	I-DNA
.	O

In	O
particular	O
,	O
the	O
c-Rel	B-protein
homodimer	I-protein
has	O
a	O
high	O
affinity	O
for	O
interleukin-6	B-protein
(	O
IL-6	B-protein
)	O
and	O
beta	B-DNA
interferon	I-DNA
kappa	I-DNA
B	I-DNA
sites	I-DNA
.	O

In	O
spite	O
of	O
its	O
association	O
with	O
p50	B-protein
in	O
vitro	O
,	O
however	O
,	O
we	O
found	O
a	O
lymphoid	B-protein
cell-specific	I-protein
nuclear	I-protein
factor	I-protein
in	O
vivo	O
that	O
contains	O
c-Rel	B-protein
but	O
not	O
p50	B-protein
epitopes	I-protein
;	O
this	O
factor	O
,	O
termed	O
IL-6	B-protein
kappa	I-protein
B	I-protein
binding	I-protein
factor	I-protein
II	I-protein
,	O
appears	O
to	O
contain	O
the	O
c-Rel	B-protein
homodimer	I-protein
and	O
preferentially	O
recognizes	O
several	O
IL-6	B-DNA
kappa	I-DNA
B-related	I-DNA
kappa	I-DNA
B	I-DNA
motifs	I-DNA
.	O

Although	O
it	O
has	O
been	O
previously	O
shown	O
that	O
the	O
IL-6	B-DNA
kappa	I-DNA
B	I-DNA
motif	I-DNA
functions	O
as	O
a	O
potent	O
IL-1/tumor	B-DNA
necrosis	I-DNA
factor-responsive	I-DNA
element	I-DNA
in	O
nonlymphoid	B-cell_type
cells	I-cell_type
,	O
its	O
activity	O
was	O
found	O
to	O
be	O
repressed	O
in	O
lymphoid	B-cell_type
cells	I-cell_type
such	O
as	O
a	O
Jurkat	B-cell_line
T-cell	I-cell_line
line	I-cell_line
.	O

We	O
also	O
present	O
evidence	O
that	O
IL-6	B-protein
kappa	I-protein
B	I-protein
binding	I-protein
factor	I-protein
II	I-protein
functions	O
as	O
a	O
repressor	O
specific	O
for	O
IL-6	B-DNA
kappa	I-DNA
B-related	I-DNA
kappa	I-DNA
B	I-DNA
motifs	I-DNA
in	O
lymphoid	B-cell_type
cells	I-cell_type
.	O

MoLEcuLar	NULL
aAnp	NULL
CELLULAR	NULL
BroLrooy	NULL
,	NULL
Apr	NULL
.	NULL

1992	NULL
,	NULL
p.	NULL
1736-1746	NULL
0270-7306/92/041736-11	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1992	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

12	NULL
,	NULL
No	NULL
.	NULL

4	NULL
A	NULL
Lymphoid	NULL
Cell-Specific	NULL
Nuclear	NULL
Factor	NULL
Containing	NULL
c-Rel-Like	NULL
Proteins	NULL
Preferentially	NULL
Interacts	NULL
with	NULL
Interleukin-6	NULL
Motifs	NULL
Whose	NULL
Activities	NULL
Are	NULL
Repressed	NULL
in	NULL
Lymphoid	NULL
Cells	NULL
KOHZO	NULL
NAKAYAMA	NULL
,	NULL
HIROKO	NULL
SHIMIZU	NULL
,	NULL
KATSUYUKI	NULL
MITOMO	NULL
,	NULL
TOMOO	NULL
WATANABE	NULL
,	NULL
SHU-ICHI	NULL
OKAMOTO	NULL
,	NULL
anp	NULL
KEN-ICHI	NULL
YAMAMOTO®*	NULL
Department	NULL
of	NULL
Molecular	NULL
Pathology	NULL
,	NULL
Cancer	NULL
Research	NULL
Institute	NULL
,	NULL
Kanazawa	NULL
University	NULL
,	NULL
13-1	NULL
Takaramachi	NULL
,	NULL
Kanazawa	NULL
,	NULL
Ishikawa	NULL
920	NULL
,	NULL
Japan	NULL
Received	NULL
25	NULL
October	NULL
1991/Accepted	NULL
23	NULL
December	NULL
1991	NULL
The	NULL
proto-oncoprotein	NULL
c-Rel	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
family	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
c-Rel	NULL
binds	NULL
to	NULL
«	NULL
B	NULL
sites	NULL
as	NULL
homodimers	NULL
as	NULL
well	NULL
as	NULL
heterodimers	NULL
with	NULL
p50	NULL
.	NULL

These	NULL
homodimers	NULL
and	NULL
heterodimers	NULL
show	NULL
distinct	NULL
DNA-binding	NULL
specificities	NULL
and	NULL
affinities	NULL
for	NULL
various	NULL
«	NULL
B	NULL
motifs	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
c-Rel	NULL
homodimer	NULL
has	NULL
a	NULL
high	NULL
affinity	NULL
for	NULL
interleukin-6	NULL
(	NULL
IL-6	NULL
)	NULL
and	NULL
beta	NULL
interferon	NULL
«	NULL
B	NULL
sites	NULL
.	NULL

In	NULL
spite	NULL
of	NULL
its	NULL
association	NULL
with	NULL
p50	NULL
in	NULL
vitro	NULL
,	NULL
however	NULL
,	NULL
we	NULL
found	NULL
a	NULL
lymphoid	NULL
cell-specific	NULL
nuclear	NULL
factor	NULL
in	NULL
vivo	NULL
that	NULL
contains	NULL
c-Rel	NULL
but	NULL
not	NULL
p50	NULL
epitopes	NULL
;	NULL
this	NULL
factor	NULL
,	NULL
termed	NULL
IL-6xB	NULL
binding	NULL
factor	NULL
II	NULL
,	NULL
appears	NULL
to	NULL
contain	NULL
the	NULL
c-Rel	NULL
homodimer	NULL
and	NULL
preferentially	NULL
recognizes	NULL
several	NULL
IL-G	NULL
«	NULL
B-related	NULL
B	NULL
motifs	NULL
.	NULL

Although	NULL
it	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
IL-6icB	NULL
motif	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
IL-1/tumor	NULL
necrosis	NULL
factor-responsive	NULL
element	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
,	NULL
its	NULL
activity	NULL
was	NULL
found	NULL
to	NULL
be	NULL
repressed	NULL
in	NULL
lymphoid	NULL
cells	NULL
such	NULL
as	NULL
a	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
.	NULL

We	NULL
also	NULL
present	NULL
evidence	NULL
that	NULL
IL-6B	NULL
binding	NULL
factor	NULL
II	NULL
functions	NULL
as	NULL
a	NULL
repressor	NULL
specific	NULL
for	NULL
IL-6xcB-related	NULL
iB	NULL
motifs	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

Nuclear	NULL
factor	NULL
«	NULL
B	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
was	NULL
originally	NULL
identified	NULL
as	NULL
a	NULL
B-cell-specific	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
an	NULL
enhancer	NULL
element	NULL
called	NULL
xB	NULL
of	NULL
the	NULL
k	NULL
immunoglobulin	NULL
light-chain	NULL
gene	NULL
(	NULL
58	NULL
)	NULL
.	NULL

It	NULL
is	NULL
now	NULL
clear	NULL
,	NULL
however	NULL
,	NULL
that	NULL
NF-KB	NULL
is	NULL
present	NULL
in	NULL
many	NULL
different	NULL
types	NULL
of	NULL
cells	NULL
and	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
diverse	NULL
cellular	NULL
genes	NULL
through	NULL
binding	NULL
to	NULL
various	NULL
kB	NULL
sequences	NULL
.	NULL

These	NULL
genes	NULL
mostly	NULL
include	NULL
those	NULL
involved	NULL
in	NULL
host	NULL
defense	NULL
,	NULL
such	NULL
as	NULL
genes	NULL
for	NULL
various	NULL
cyto-kines	NULL
,	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
chains	NULL
,	NULL
cell	NULL
adhesion	NULL
mole-cules	NULL
,	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
class	NULL
I	NULL
and	NULL
II	NULL
antigens	NULL
,	NULL
and	NULL
acute-phase	NULL
proteins	NULL
;	NULL
NF-KB	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
binds	NULL
to	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
several	NULL
viral	NULL
enhancers	NULL
such	NULL
as	NULL
those	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
,	NULL
cytomegalovirus	NULL
,	NULL
and	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
and	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
viral	NULL
activation	NULL
(	NULL
2	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Although	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
constitutively	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
B	NULL
cells	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
an	NULL
inducible	NULL
nuclear	NULL
factor	NULL
in	NULL
other	NULL
types	NULL
of	NULL
cells	NULL
(	NULL
59	NULL
)	NULL
.	NULL

Subsequent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
preexists	NULL
in	NULL
the	NULL
cytoplasm	NULL
in	NULL
the	NULL
inactive	NULL
form	NULL
complexed	NULL
with	NULL
an	NULL
inhibitory	NULL
protein	NULL
termed	NULL
IxB	NULL
;	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
stimulation	NULL
of	NULL
cells	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
agents	NULL
such	NULL
as	NULL
phorbol	NULL
ester	NULL
,	NULL
bacterial	NULL
lipopoly-saccharide	NULL
,	NULL
virus	NULL
,	NULL
double-stranded	NULL
RNA	NULL
,	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-	NULL
«	NULL
)	NULL
,	NULL
and	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
Tax	NULL
transactivator	NULL
results	NULL
in	NULL
the	NULL
dissociation	NULL
of	NULL
the	NULL
IxB/NF-	NULL
«	NULL
B	NULL
complex	NULL
and	NULL
subsequent	NULL
translocation	NULL
of	NULL
NF-KB	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
A	NULL
or	NULL
C	NULL
and	NULL
subsequent	NULL
phosphorylation	NULL
of	NULL
IxB	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
be	NULL
a	NULL
major	NULL
activation	NULL
pathway	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
19	NULL
,	NULL
61	NULL
)	NULL
,	NULL
other	NULL
studies	NULL
suggest	NULL
the	NULL
involvement	NULL
of	NULL
other	NULL
signal	NULL
transduction	NULL
pathways	NULL
as	NULL
well	NULL
(	NULL
27	NULL
,	NULL
48	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
contains	NULL
two	NULL
proteins	NULL
of	NULL
50	NULL
and	NULL
65	NULL
kDa	NULL
termed	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
respectively	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Although	NULL
earlier	NULL
studies	NULL
showed	NULL
that	NULL
only	NULL
p50	NULL
subunits	NULL
have	NULL
DNA-binding	NULL
properties	NULL
and	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

1736	NULL
therefore	NULL
suggested	NULL
that	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
mediated	NULL
through	NULL
its	NULL
p50	NULL
portion	NULL
(	NULL
5	NULL
,	NULL
32	NULL
)	NULL
,	NULL
more	NULL
recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
p65	NULL
can	NULL
also	NULL
bind	NULL
DNA	NULL
apparently	NULL
as	NULL
homodimers	NULL
(	NULL
53	NULL
,	NULL
56	NULL
,	NULL
64	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
proteins	NULL
bind	NULL
to	NULL
kB	NULL
sequences	NULL
primarily	NULL
as	NULL
heterodimers	NULL
(	NULL
p50/p65	NULL
)	NULL
but	NULL
also	NULL
bind	NULL
as	NULL
homodimers	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
p50	NULL
homodimer	NULL
shows	NULL
a	NULL
high	NULL
affinity	NULL
for	NULL
symmetrical	NULL
«	NULL
B	NULL
motifs	NULL
such	NULL
as	NULL
xB	NULL
sequences	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
gene	NULL
promoters	NULL
(	NULL
6	NULL
,	NULL
34	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
asymmetric	NULL
prototype	NULL
«	NULL
kB	NULL
motifs	NULL
found	NULL
in	NULL
the	NULL
enhancers	NULL
of	NULL
the	NULL
k	NULL
immunoglobulin	NULL
gene	NULL
and	NULL
in	NULL
the	NULL
SV40	NULL
and	NULL
HIV	NULL
viral	NULL
enhancers	NULL
are	NULL
weak	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
p50	NULL
homodimer	NULL
but	NULL
have	NULL
a	NULL
high	NULL
affinity	NULL
for	NULL
the	NULL
p50/p65	NULL
heterodimer	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
(	NULL
6	NULL
,	NULL
63	NULL
)	NULL
.	NULL

Since	NULL
p50	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
a	NULL
previously	NULL
characterized	NULL
constitutive	NULL
nuclear	NULL
factor	NULL
that	NULL
specifically	NULL
binds	NULL
to	NULL
the	NULL
MHC	NULL
xB	NULL
sequence	NULL
(	NULL
34	NULL
)	NULL
,	NULL
the	NULL
p50	NULL
homodimer	NULL
appears	NULL
to	NULL
be	NULL
physiologically	NULL
present	NULL
in	NULL
vivo	NULL
(	NULL
6	NULL
,	NULL
34	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
p50	NULL
or	NULL
p65	NULL
homodimers	NULL
have	NULL
any	NULL
physiological	NULL
roles	NULL
in	NULL
vivo	NULL
.	NULL

Recent	NULL
cloning	NULL
and	NULL
sequencing	NULL
of	NULL
cDNA	NULL
clones	NULL
encoding	NULL
p65	NULL
and	NULL
a	NULL
110-kDa	NULL
precursor	NULL
of	NULL
p50	NULL
have	NULL
revealed	NULL
an	NULL
extensive	NULL
sequence	NULL
homology	NULL
between	NULL
these	NULL
proteins	NULL
in	NULL
their	NULL
N-terminal	NULL
portions	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
predicted	NULL
sequences	NULL
of	NULL
these	NULL
proteins	NULL
are	NULL
also	NULL
highly	NULL
homologous	NULL
to	NULL
those	NULL
of	NULL
the	NULL
c-rel	NULL
proto-oncogene	NULL
and	NULL
of	NULL
the	NULL
Drosophila	NULL
maternal	NULL
morphogen	NULL
dorsal	NULL
gene	NULL
;	NULL
in	NULL
particular	NULL
,	NULL
p65	NULL
is	NULL
related	NULL
to	NULL
c-Rel	NULL
more	NULL
closely	NULL
than	NULL
to	NULL
p50	NULL
(	NULL
9	NULL
,	NULL
20	NULL
,	NULL
21	NULL
,	NULL
47	NULL
,	NULL
53	NULL
,	NULL
56	NULL
)	NULL
.	NULL

c-rel	NULL
is	NULL
the	NULL
cellular	NULL
cognate	NULL
of	NULL
v-rel	NULL
,	NULL
the	NULL
transforming	NULL
gene	NULL
of	NULL
highly	NULL
oncogenic	NULL
reticuloendotheliosis	NULL
virus	NULL
strain	NULL
T	NULL
that	NULL
induces	NULL
an	NULL
acute	NULL
fatal	NULL
lymphoma	NULL
in	NULL
young	NULL
birds	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
products	NULL
of	NULL
the	NULL
c-re/	NULL
and	NULL
dorsal	NULL
genes	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
their	NULL
sequence	NULL
similarity	NULL
to	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
show	NULL
unique	NULL
subcellular	NULL
partitioning	NULL
,	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
does	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
more	NULL
recently	NULL
that	NULL
the	NULL
c-Rel	NULL
and	NULL
v-Rel	NULL
proteins	NULL
can	NULL
recognize	NULL
some	NULL
«	NULL
B	NULL
sequences	NULL
(	NULL
8	NULL
,	NULL
28	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
proteins	NULL
constitute	NULL
a	NULL
distinct	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
recognizing	NULL
xB	NULL
elements	NULL
and	NULL
showing	NULL
unique	NULL
subcellular	NULL
partitioning	NULL
.	NULL

However	NULL
,	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
established	NULL
that	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
various	NULL
complexes	NULL
of	NULL
the	NULL
members	NULL
of	NULL
this	NULL
family	NULL
have	NULL
different	NULL
DNA-binding	NULL
specificities	NULL
or	NULL
affinities	NULL
and	NULL
transcriptional	NULL
potentials	NULL
or	NULL
are	NULL
present	NULL
physiologically	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
c-Rel	NULL
homodimers	NULL
and	NULL
p50/c-Rel	NULL
heterodimers	NULL
show	NULL
distinct	NULL
DNA-binding	NULL
specificities	NULL
and	NULL
affinities	NULL
for	NULL
various	NULL
kB	NULL
motifs	NULL
.	NULL

Particularly	NULL
,	NULL
the	NULL
c-Rel	NULL
homodimer	NULL
has	NULL
a	NULL
strong	NULL
affinity	NULL
for	NULL
a	NULL
«	NULL
B	NULL
motif	NULL
found	NULL
in	NULL
the	NULL
IL-6	NULL
gene	NULL
promoter	NULL
,	NULL
and	NULL
the	NULL
p50/c-Rel	NULL
heterodimer	NULL
can	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
IL-6	NULL
«	NULL
B	NULL
motif	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
c-Rel	NULL
homodimer	NULL
.	NULL

We	NULL
also	NULL
show	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
lymphoid	NULL
cell-specific	NULL
nuclear	NULL
factor	NULL
that	NULL
is	NULL
distinct	NULL
from	NULL
c-Rel	NULL
homodimers	NULL
or	NULL
p50/c-Rel	NULL
heterodimers	NULL
but	NULL
contains	NULL
c-Rel	NULL
epitopes	NULL
and	NULL
has	NULL
an	NULL
IL-6	NULL
«	NULL
B-specific	NULL
DNA-binding	NULL
property	NULL
.	NULL

Evidence	NULL
is	NULL
also	NULL
presented	NULL
that	NULL
this	NULL
factor	NULL
might	NULL
function	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
specific	NULL
for	NULL
the	NULL
IL-6	NULL
«	NULL
B-related	NULL
motifs	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

IL-6	NULL
is	NULL
a	NULL
pleiotropic	NULL
cytokine	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
,	NULL
he-matopoiesis	NULL
,	NULL
and	NULL
inflammation	NULL
(	NULL
35	NULL
)	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
IL-6	NULL
«	NULL
kB	NULL
motif	NULL
is	NULL
an	NULL
important	NULL
promoter	NULL
element	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IL-6	NULL
gene	NULL
expression	NULL
(	NULL
42	NULL
,	NULL
60	NULL
,	NULL
68	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
results	NULL
presented	NULL
in	NULL
this	NULL
paper	NULL
suggest	NULL
that	NULL
c-Rel-related	NULL
factors	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
host	NULL
defense	NULL
through	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
and	NULL
possibly	NULL
also	NULL
of	NULL
some	NULL
other	NULL
cytokine	NULL
genes	NULL
having	NULL
IL-6	NULL
«	NULL
B-related	NULL
promoter	NULL
elements	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cloning	NULL
of	NULL
cDNAs	NULL
encoding	NULL
human	NULL
p50	NULL
and	NULL
c-Rel	NULL
by	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

The	NULL
following	NULL
polymerase	NULL
chain	NULL
reaction	NULL
primers	NULL
were	NULL
synthesized	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
sequences	NULL
of	NULL
human	NULL
p50	NULL
and	NULL
c-re/	NULL
cDNAs	NULL
(	NULL
11	NULL
,	NULL
34	NULL
)	NULL
:	NULL
p50	NULL
5	NULL
'	NULL
primer	NULL
,	NULL
-	NULL
5'-AATCTAGACTCGCCACCCGGCTTCAGA-3	NULL
'	NULL
(	NULL
nucleotides	NULL
152	NULL
to	NULL
173	NULL
in	NULL
the	NULL
5°	NULL
noncoding	NULL
region	NULL
;	NULL
this	NULL
primer	NULL
contains	NULL
an	NULL
Xbal	NULL
site	NULL
[	NULL
underlined	NULL
]	NULL
)	NULL
;	NULL
p50	NULL
3	NULL
'	NULL
primer	NULL
,	NULL
(	NULL
nucleotides	NULL
1665	NULL
to	NULL
1686	NULL
)	NULL
;	NULL
c-Rel	NULL
5	NULL
primer	NULL
,	NULL
5-TACATATGGCCTCCGGTGCGT	NULL
ATAAC-3	NULL
'	NULL
(	NULL
nucleotides	NULL
178	NULL
to	NULL
199	NULL
;	NULL
this	NULL
primer	NULL
contains	NULL
an	NULL
NdeI	NULL
site	NULL
[	NULL
underlined	NULL
]	NULL
in	NULL
the	NULL
methionine	NULL
start	NULL
codon	NULL
)	NULL
;	NULL
and	NULL
c-Rel	NULL
3	NULL
'	NULL
primer	NULL
,	NULL
AATT-3	NULL
'	NULL
(	NULL
nucleotides	NULL
2021	NULL
to	NULL
2043	NULL
)	NULL
.	NULL

Two	NULL
micrograms	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
isolated	NULL
from	NULL
HeLa	NULL
cells	NULL
was	NULL
reverse	NULL
transcribed	NULL
;	NULL
1/10	NULL
of	NULL
the	NULL
reverse	NULL
transcripts	NULL
was	NULL
run	NULL
for	NULL
each	NULL
reaction	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
37	NULL
)	NULL
,	NULL
using	NULL
35	NULL
cycles	NULL
of	NULL
1	NULL
min	NULL
at	NULL
90°C	NULL
,	NULL
2	NULL
min	NULL
at	NULL
55°C	NULL
,	NULL
and	NULL
3	NULL
min	NULL
at	NULL
70°C	NULL
.	NULL

Then	NULL
1.5-kb	NULL
p50	NULL
cDNA	NULL
(	NULL
nucleotides	NULL
152	NULL
to	NULL
1686	NULL
,	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
502	NULL
)	NULL
and	NULL
1.8-kb	NULL
c-ref	NULL
cDNA	NULL
(	NULL
nucleotides	NULL
178	NULL
to	NULL
2043	NULL
,	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
587	NULL
)	NULL
were	NULL
amplified	NULL
,	NULL
gel	NULL
purified	NULL
on	NULL
a	NULL
0.7	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
Smal	NULL
or	NULL
Hincll	NULL
site	NULL
of	NULL
the	NULL
Bluescript	NULL
pKSII*	NULL
vector	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
previously	NULL
reported	NULL
clone	NULL
isolated	NULL
from	NULL
a	NULL
Daudi	NULL
cDNA	NULL
library	NULL
(	NULL
11	NULL
)	NULL
,	NULL
our	NULL
c-rel	NULL
cDNA	NULL
clone	NULL
did	NULL
not	NULL
contain	NULL
an	NULL
in-frame	NULL
96-bp	NULL
Alu	NULL
fragment	NULL
.	NULL

Synthesis	NULL
of	NULL
human	NULL
p50	NULL
and	NULL
c-Rel	NULL
proteins	NULL
in	NULL
bacteria	NULL
and	NULL
antibody	NULL
preparation	NULL
.	NULL

p50	NULL
cDNA	NULL
cloned	NULL
into	NULL
pKSII	NULL
*	NULL
was	NULL
cut	NULL
out	NULL
by	NULL
BamHI	NULL
and	NULL
recloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
the	NULL
pET-3b	NULL
expression	NULL
vector	NULL
(	NULL
55	NULL
)	NULL
;	NULL
this	NULL
p50	NULL
expression	NULL
vector	NULL
encodes	NULL
the	NULL
63-kDa	NULL
p50	NULL
protein	NULL
(	NULL
amino	NULL
acids	NULL
18	NULL
to	NULL
504	NULL
of	NULL
the	NULL
p50	NULL
precursor	NULL
)	NULL
,	NULL
which	NULL
is	NULL
larger	NULL
than	NULL
the	NULL
physiological	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
5	NULL
)	NULL
.	NULL

c-re/	NULL
cDNA	NULL
was	NULL
cut	NULL
out	NULL
by	NULL
Nde	NULL
!	NULL

and	NULL
cloned	NULL
into	NULL
the	NULL
Nde	NULL
!	NULL

site	NULL
of	NULL
the	NULL
pET-3a	NULL
expression	NULL
vector	NULL
;	NULL
this	NULL
plasmid	NULL
codes	NULL
for	NULL
the	NULL
near-full-length	NULL
79-kDa	NULL
c-Rel	NULL
protein	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
582	NULL
)	NULL
(	NULL
11	NULL
)	NULL
.	NULL

These	NULL
expression	NULL
vectors	NULL
were	NULL
introduced	NULL
into	NULL
Escherichia	NULL
coli	NULL
BL21	NULL
.	NULL

The	NULL
transformed	NULL
bacteria	NULL
were	NULL
grown	NULL
and	NULL
then	NULL
induced	NULL
with	NULL
1	NULL
mM	NULL
isopropylthiogalactopyranoside	NULL
(	NULL
IPTG	NULL
)	NULL
for	NULL
2	NULL
to	NULL
3	NULL
h.	NULL
Most	NULL
of	NULL
INTERACTIONS	NULL
OF	NULL
c-Rel-RELATED	NULL
FACTORS	NULL
WITH	NULL
IL-6	NULL
«	NULL
B	NULL
1737	NULL
the	NULL
p50	NULL
protein	NULL
remained	NULL
soluble	NULL
after	NULL
extraction	NULL
of	NULL
harvested	NULL
bacteria	NULL
and	NULL
was	NULL
purified	NULL
by	NULL
DEAE	NULL
and	NULL
phosphocellulose	NULL
column	NULL
chromatography	NULL
.	NULL

The	NULL
c-Rel	NULL
protein	NULL
which	NULL
was	NULL
largely	NULL
in	NULL
the	NULL
inclusion	NULL
body	NULL
fraction	NULL
after	NULL
centrifugation	NULL
was	NULL
purified	NULL
by	NULL
DEAE-Sephacel	NULL
column	NULL
chromatography	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
8	NULL
M	NULL
urea	NULL
and	NULL
subsequently	NULL
renatured	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Rabbit	NULL
antisera	NULL
were	NULL
prepared	NULL
by	NULL
six	NULL
subcutaneous	NULL
injections	NULL
of	NULL
100	NULL
ug	NULL
of	NULL
proteins	NULL
with	NULL
complete	NULL
Freund	NULL
's	NULL
adjuvant	NULL
at	NULL
weekly	NULL
intervals	NULL
.	NULL

The	NULL
specificities	NULL
of	NULL
these	NULL
antisera	NULL
were	NULL
established	NULL
by	NULL
Ouchterlony	NULL
and	NULL
Western	NULL
immunoblot	NULL
analysis	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
,	NULL
translation	NULL
,	NULL
and	NULL
immunoprecipita-tion	NULL
.	NULL

Two	NULL
micrograms	NULL
of	NULL
pBluescript	NULL
(	NULL
pKSII*	NULL
)	NULL
containing	NULL
either	NULL
p50	NULL
cDNA	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
504	NULL
)	NULL
or	NULL
c-re/	NULL
cDNA	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
587	NULL
)	NULL
was	NULL
linearized	NULL
with	NULL
EcoRI	NULL
which	NULL
recognized	NULL
EcoRI	NULL
sites	NULL
in	NULL
the	NULL
polylinker	NULL
of	NULL
pKSII*	NULL
.	NULL

RNAs	NULL
were	NULL
synthesized	NULL
in	NULL
a	NULL
20-pl	NULL
reaction	NULL
mixture	NULL
,	NULL
using	NULL
T7	NULL
RNA	NULL
polymerase	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Two-microliter	NULL
samples	NULL
of	NULL
RNAs	NULL
were	NULL
used	NULL
for	NULL
in	NULL
vitro	NULL
translation	NULL
,	NULL
using	NULL
a	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
in	NULL
a	NULL
30-ul	NULL
reaction	NULL
mixture	NULL
containing	NULL
25	NULL
wCi	NULL
of	NULL
*°S-labeled	NULL
methionine	NULL
as	NULL
recommended	NULL
by	NULL
manufacturer	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
51	NULL
)	NULL
in	NULL
a	NULL
100-pl	NULL
volume	NULL
containing	NULL
1.2	NULL
pl	NULL
of	NULL
antisera	NULL
,	NULL
40	NULL
pl	NULL
of	NULL
Immsorbin	NULL
(	NULL
Wako	NULL
Co.	NULL
Ltd.	NULL
)	NULL
,	NULL
and	NULL
3	NULL
pl	NULL
of	NULL
*°S-labeled	NULL
p50	NULL
translated	NULL
products	NULL
,	NULL
1	NULL
wl	NULL
of	NULL
c-re/	NULL
products	NULL
,	NULL
or	NULL
3	NULL
ul	NULL
of	NULL
cotranslated	NULL
products	NULL
of	NULL
p50	NULL
and	NULL
c-re/	NULL
.	NULL

The	NULL
immune	NULL
complexes	NULL
were	NULL
analyzed	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-10	NULL
%	NULL
poly-acrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
protein-DNA	NULL
interaction	NULL
by	NULL
EMSA	NULL
.	NULL

The	NULL
probes	NULL
used	NULL
for	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
were	NULL
prepared	NULL
from	NULL
plasmids	NULL
containing	NULL
various	NULL
«	NULL
B	NULL
sequences	NULL
cloned	NULL
in	NULL
the	NULL
multiple	NULL
cloning	NULL
site	NULL
of	NULL
pBLCAT3	NULL
by	NULL
cutting	NULL
at	NULL
the	NULL
5'-end	NULL
XbaI	NULL
and	NULL
3'-end	NULL
Hinfl	NULL
sites	NULL
and	NULL
were	NULL
3	NULL
'	NULL
end	NULL
labeled	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
60	NULL
)	NULL
.	NULL

Nuclear	NULL
and	NULL
cyto-solic	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
unstimulated	NULL
cells	NULL
or	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-la	NULL
«	NULL
or	NULL
TNF-	NULL
«	NULL
for	NULL
30	NULL
min	NULL
by	NULL
the	NULL
methods	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
17	NULL
)	NULL
and	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
(	NULL
3	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

IL-6	NULL
«	NULL
B	NULL
binding	NULL
factor	NULL
II	NULL
(	NULL
BFII	NULL
)	NULL
was	NULL
partially	NULL
fractioned	NULL
from	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
by	NULL
gel	NULL
filtration	NULL
on	NULL
Sephacryl	NULL
$	NULL
-400	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
was	NULL
partially	NULL
purified	NULL
from	NULL
nuclear	NULL
extracts	NULL
of	NULL
TNF-stimulated	NULL
HeLa	NULL
cells	NULL
by	NULL
DEAE-cellulose	NULL
,	NULL
phosphocellulose	NULL
(	NULL
P11	NULL
)	NULL
,	NULL
and	NULL
DNA-cellulose	NULL
column	NULL
chromatography	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
60	NULL
)	NULL
except	NULL
that	NULL
polyvinyl	NULL
alcohol	NULL
was	NULL
omitted	NULL
.	NULL

For	NULL
heterodimerization	NULL
,	NULL
recombinant	NULL
p50	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
recombinant	NULL
c-Rel	NULL
proteins	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
10	NULL
min	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
binding	NULL
buffer	NULL
before	NULL
addition	NULL
of	NULL
DNA	NULL
probes	NULL
.	NULL

In	NULL
the	NULL
experiments	NULL
using	NULL
antibodies	NULL
,	NULL
1	NULL
ul	NULL
of	NULL
antisera	NULL
was	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
nuclear	NULL
extracts	NULL
,	NULL
purified	NULL
fractions	NULL
,	NULL
or	NULL
recombinant	NULL
proteins	NULL
in	NULL
the	NULL
binding	NULL
buffer	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
DNA	NULL
probes	NULL
.	NULL

DNA	NULL
transfection	NULL
and	NULL
analysis	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
genes	NULL
containing	NULL
various	NULL
kB	NULL
motifs	NULL
were	NULL
constructed	NULL
by	NULL
inserting	NULL
synthetic	NULL
«	NULL
B	NULL
motifs	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
IL-6	NULL
TATA	NULL
element	NULL
as	NULL
described	NULL
before	NULL
(	NULL
60	NULL
)	NULL
.	NULL

For	NULL
the	NULL
expression	NULL
of	NULL
Tax	NULL
proteins	NULL
,	NULL
pHTLV-1	NULL
Tax	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
Tax	NULL
coding	NULL
region	NULL
of	NULL
HTLV-1	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
HTLV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
,	NULL
was	NULL
used	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Mouse	NULL
L-TK~	NULL
,	NULL
HeLa	NULL
,	NULL
and	NULL
Hep3B	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

The	NULL
human	NULL
T-cell	NULL
line	NULL
Jurkat	NULL
was	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
2	NULL
pug	NULL
of	NULL
CAT	NULL
reporter	NULL
genes	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
expression	NULL
vectors	NULL
per	NULL
plate	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
as	NULL
described	NULL
1738	NULL
NAKAYAMA	NULL
ET	NULL
AL	NULL
.	NULL

probe	NULL
:	NULL
S	NULL
el	NULL
so	NULL
so	NULL
60	NULL
6	NULL
c	NULL
200	NULL
1000100010001000	NULL
ng	NULL
\	NULL
)	NULL
bi	NULL
pero	NULL
-=	NULL
#	NULL
4	NULL
``	NULL
~	NULL
>	NULL
u	NULL
,	NULL
.	NULL

'*-	NULL
Mor	NULL
.	NULL

Cer	NULL
.	NULL

Bio	NULL
.	NULL

c-rel	NULL
probe	NULL
$	NULL
M	NULL
p50	NULL
so	NULL
30	NULL
30	NULL
30	NULL
30	NULL
30	NULL
30	NULL
C	NULL
30	NULL
30	NULL
3G	NULL
C	NULL
rel	NULL
400	NULL
600	NULL
8001000	NULL
400	NULL
600	NULL
800	NULL
1000	NULL
400	NULL
600	NULL
800	NULL
100	NULL
``	NULL
``	NULL
Wo0	NULL
--	NULL
.s	NULL
:	NULL
=	NULL
«	NULL
uuuli00~	NULL
``	NULL
=	NULL
``	NULL
==	NULL
au	NULL
FIG	NULL
.	NULL

1.	NULL
c-Rel	NULL
binds	NULL
various	NULL
«	NULL
B	NULL
motifs	NULL
as	NULL
homodimers	NULL
as	NULL
well	NULL
as	NULL
heterodimers	NULL
with	NULL
p50	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Formation	NULL
of	NULL
c-Rel	NULL
homodimers	NULL
and	NULL
p50/c-Rel	NULL
heterodimers	NULL
.	NULL

Recombinant	NULL
p50	NULL
and	NULL
c-Rel	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
SV40xB	NULL
probes	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
p50	NULL
(	NULL
60	NULL
ng	NULL
)	NULL
;	NULL
2	NULL
>	NULL
p50	NULL
(	NULL
60	NULL
ng	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
200	NULL
ng	NULL
)	NULL
;	NULL
3	NULL
,	NULL
p50	NULL
(	NULL
60	NULL
ng	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
1000	NULL
ng	NULL
)	NULL
;	NULL
4	NULL
,	NULL
p50	NULL
(	NULL
6	NULL
ng	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
1,000	NULL
ng	NULL
)	NULL
;	NULL
5	NULL
,	NULL
p50	NULL
(	NULL
3	NULL
ng	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
1,000	NULL
ng	NULL
)	NULL
;	NULL
6	NULL
,	NULL
c-Rel	NULL
(	NULL
1,000	NULL
ng	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Binding	NULL
specificities	NULL
of	NULL
p50	NULL
homodimers	NULL
,	NULL
p50/c-Rel	NULL
heterodimers	NULL
,	NULL
and	NULL
c-Rel	NULL
homodimers	NULL
for	NULL
SV40	NULL
(	NULL
$	NULL
)	NULL
,	NULL
MHC	NULL
(	NULL
M	NULL
)	NULL
,	NULL
and	NULL
IL-6	NULL
(	NULL
1	NULL
)	NULL
KB	NULL
probes	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
to	NULL
3	NULL
,	NULL
p50	NULL
(	NULL
60	NULL
ng	NULL
)	NULL
;	NULL
4	NULL
to	NULL
6	NULL
,	NULL
c-Rel	NULL
(	NULL
600	NULL
ng	NULL
)	NULL
;	NULL
7	NULL
to	NULL
9	NULL
,	NULL
p50	NULL
(	NULL
60	NULL
ng	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
600	NULL
ng	NULL
)	NULL
;	NULL
10	NULL
,	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
HeLa	NULL
cells	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Differential	NULL
affinities	NULL
of	NULL
p50/c-Rel	NULL
heterodimers	NULL
and	NULL
c-Rel	NULL
homodimers	NULL
for	NULL
SV40	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
,	NULL
MHC	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
,	NULL
and	NULL
IL-6	NULL
(	NULL
lanes	NULL
9	NULL
to	NULL
12	NULL
)	NULL
kB	NULL
probes	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
5	NULL
,	NULL
and	NULL
9	NULL
,	NULL
p50	NULL
(	NULL
30	NULL
ng	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
400	NULL
ng	NULL
)	NULL
;	NULL
2	NULL
,	NULL
6	NULL
,	NULL
and	NULL
10	NULL
,	NULL
p50	NULL
(	NULL
30	NULL
ng	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
600	NULL
ng	NULL
)	NULL
;	NULL
3	NULL
,	NULL
7	NULL
,	NULL
and	NULL
11	NULL
,	NULL
p50	NULL
(	NULL
30	NULL
ng	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
800	NULL
ng	NULL
)	NULL
;	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
12	NULL
,	NULL
p50	NULL
(	NULL
30	NULL
ng	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
1,000	NULL
ng	NULL
)	NULL
.	NULL

previously	NULL
(	NULL
44	NULL
)	NULL
.	NULL

For	NULL
TNF	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
recombinant	NULL
TNF-	NULL
«	NULL
(	NULL
34	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
24	NULL
h	NULL
before	NULL
being	NULL
harvested	NULL
for	NULL
determination	NULL
of	NULL
CAT	NULL
activity	NULL
(	NULL
23	NULL
)	NULL
.	NULL

RESULTS	NULL
c-Rel	NULL
homodimers	NULL
and	NULL
p50/c-Rel	NULL
heterodimers	NULL
show	NULL
distinct	NULL
DNA-binding	NULL
specificities	NULL
and	NULL
affinities	NULL
for	NULL
various	NULL
B	NULL
motifs	NULL
.	NULL

The	NULL
human	NULL
p50	NULL
protein	NULL
containing	NULL
the	NULL
N-terminal	NULL
DNA-binding	NULL
portion	NULL
(	NULL
amino	NULL
acids	NULL
18	NULL
to	NULL
504	NULL
)	NULL
and	NULL
near-full-length	NULL
c-Rel	NULL
protein	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
582	NULL
)	NULL
were	NULL
synthesized	NULL
in	NULL
bacteria	NULL
by	NULL
using	NULL
the	NULL
pET3	NULL
expression	NULL
system	NULL
.	NULL

The	NULL
purified	NULL
recombinant	NULL
p50	NULL
and	NULL
c-Rel	NULL
proteins	NULL
had	NULL
apparent	NULL
sizes	NULL
of	NULL
63	NULL
and	NULL
79	NULL
kDa	NULL
,	NULL
respectively	NULL
,	NULL
on	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
recombinant	NULL
p50	NULL
is	NULL
larger	NULL
than	NULL
the	NULL
physiological	NULL
p50	NULL
subunit	NULL
(	NULL
5	NULL
)	NULL
,	NULL
since	NULL
the	NULL
p50	NULL
precursor	NULL
is	NULL
presumably	NULL
processed	NULL
at	NULL
sites	NULL
more	NULL
N	NULL
terminal	NULL
to	NULL
amino	NULL
acid	NULL
504	NULL
of	NULL
p50	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
c-Rel	NULL
recognizes	NULL
«	NULL
B	NULL
motifs	NULL
as	NULL
a	NULL
homodimer	NULL
as	NULL
well	NULL
as	NULL
a	NULL
heterodimer	NULL
with	NULL
p50	NULL
,	NULL
we	NULL
used	NULL
the	NULL
prototype	NULL
«	NULL
B	NULL
sequence	NULL
(	NULL
SV40xkB	NULL
,	NULL
GGGGACTTTCCAC	NULL
)	NULL
found	NULL
in	NULL
the	NULL
k	NULL
immuno-globulin	NULL
,	NULL
HIV	NULL
,	NULL
and	NULL
SV40	NULL
enhancers	NULL
as	NULL
a	NULL
probe	NULL
for	NULL
EMSA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
the	NULL
c-Rel	NULL
protein	NULL
formed	NULL
a	NULL
DNA/protein	NULL
complex	NULL
,	NULL
the	NULL
mobility	NULL
of	NULL
which	NULL
was	NULL
considerably	NULL
slower	NULL
than	NULL
that	NULL
of	NULL
the	NULL
p50/DNA	NULL
complex	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
being	NULL
consistent	NULL
with	NULL
the	NULL
larger	NULL
size	NULL
of	NULL
the	NULL
c-Rel	NULL
protein	NULL
.	NULL

Surprisingly	NULL
,	NULL
without	NULL
combined	NULL
renaturation	NULL
,	NULL
mixing	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
10	NULL
min	NULL
of	NULL
p50	NULL
and	NULL
c-Rel	NULL
proteins	NULL
with	NULL
«	NULL
B	NULL
probes	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
DNA/protein	NULL
complex	NULL
,	NULL
the	NULL
mobility	NULL
of	NULL
which	NULL
was	NULL
intermediate	NULL
between	NULL
those	NULL
of	NULL
p50	NULL
and	NULL
c-re/	NULL
DNA/protein	NULL
complexes	NULL
(	NULL
lane	NULL
2	NULL
to	NULL
5	NULL
)	NULL
and	NULL
was	NULL
comparable	NULL
with	NULL
that	NULL
of	NULL
HeLa-derived	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
c-Rel	NULL
proteins	NULL
can	NULL
bind	NULL
DNA	NULL
as	NULL
a	NULL
homodimer	NULL
but	NULL
also	NULL
as	NULL
a	NULL
heterodimer	NULL
with	NULL
p50	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
results	NULL
of	NULL
competition	NULL
experiments	NULL
fully	NULL
confirmed	NULL
DNA-binding	NULL
specificities	NULL
of	NULL
the	NULL
c-Rel-mediated	NULL
nucleoprotein	NULL
complex	NULL
formation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Figure	NULL
1A	NULL
also	NULL
shows	NULL
that	NULL
the	NULL
relative	NULL
amounts	NULL
of	NULL
the	NULL
p50/c-Rel	NULL
heterodimers	NULL
formed	NULL
were	NULL
dependent	NULL
on	NULL
the	NULL
relative	NULL
amounts	NULL
of	NULL
p50	NULL
and	NULL
c-Rel	NULL
proteins	NULL
present	NULL
in	NULL
the	NULL
incubation	NULL
mixture	NULL
:	NULL
10	NULL
times	NULL
more	NULL
c-Rel	NULL
proteins	NULL
were	NULL
required	NULL
for	NULL
equivalence	NULL
in	NULL
p50/c-Rel	NULL
heterodimer	NULL
formation	NULL
(	NULL
600	NULL
to	NULL
1,000	NULL
ng	NULL
of	NULL
c-Rel	NULL
versus	NULL
60	NULL
ng	NULL
of	NULL
p50	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
.	NULL

This	NULL
result	NULL
can	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
bacterially	NULL
synthesized	NULL
c-Rel	NULL
proteins	NULL
are	NULL
not	NULL
completely	NULL
renatured	NULL
after	NULL
resolubilization	NULL
;	NULL
bacterial	NULL
p50	NULL
proteins	NULL
,	NULL
by	NULL
contrast	NULL
,	NULL
remain	NULL
soluble	NULL
,	NULL
and	NULL
the	NULL
purification	NULL
of	NULL
p50	NULL
does	NULL
not	NULL
require	NULL
a	NULL
solubilization	NULL
step	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
relative	NULL
inefficiency	NULL
of	NULL
c-Rel	NULL
proteins	NULL
may	NULL
be	NULL
an	NULL
intrinsic	NULL
property	NULL
.	NULL

We	NULL
then	NULL
tested	NULL
whether	NULL
c-Rel	NULL
homodimers	NULL
and	NULL
c-Rel/p50	NULL
heterodimers	NULL
show	NULL
different	NULL
DNA-binding	NULL
specificities	NULL
or	NULL
affinities	NULL
for	NULL
different	NULL
«	NULL
kB	NULL
sequences	NULL
.	NULL

We	NULL
used	NULL
MHCKB	NULL
(	NULL
GGGGATTCCCC	NULL
)	NULL
and	NULL
IL-6	NULL
«	NULL
B	NULL
(	NULL
GGGATTTTCCC	NULL
)	NULL
motifs	NULL
in	NULL
addition	NULL
to	NULL
SV40	NULL
«	NULL
B	NULL
as	NULL
probes	NULL
and	NULL
used	NULL
fixed	NULL
amounts	NULL
of	NULL
p50	NULL
(	NULL
60	NULL
ng	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
600	NULL
ng	NULL
)	NULL
.	NULL

Figure	NULL
1B	NULL
shows	NULL
representative	NULL
EMSA	NULL
results	NULL
.	NULL

As	NULL
previously	NULL
shown	NULL
(	NULL
34	NULL
,	NULL
63	NULL
)	NULL
,	NULL
the	NULL
p50	NULL
homodimer	NULL
had	NULL
a	NULL
higher	NULL
affinity	NULL
for	NULL
symmetrical	NULL
«	NULL
B	NULL
motifs	NULL
such	NULL
as	NULL
the	NULL
MHCxB	NULL
motif	NULL
than	NULL
for	NULL
the	NULL
asymmetrical	NULL
SV40xB	NULL
motif	NULL
;	NULL
the	NULL
affinity	NULL
of	NULL
p50	NULL
for	NULL
was	NULL
intermediate	NULL
between	NULL
them	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
.	NULL

The	NULL
c-Rel	NULL
homodimer	NULL
also	NULL
showed	NULL
only	NULL
weak	NULL
binding	NULL
to	NULL
the	NULL
asymmetrical	NULL
SV40kB	NULL
motif	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
p50/c-Rel	NULL
heterodimer	NULL
showed	NULL
comparable	NULL
binding	NULL
to	NULL
both	NULL
symmetrical	NULL
(	NULL
MHCKB	NULL
)	NULL
and	NULL
asymmetrical	NULL
(	NULL
SV40xB	NULL
)	NULL
motifs	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
while	NULL
the	NULL
p50/c-Rel	NULL
heterodimer/DNA	NULL
complexes	NULL
were	NULL
predominantly	NULL
formed	NULL
with	NULL
MHC	NULL
and	NULL
SV40	NULL
kB	NULL
probes	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
significant	NULL
amounts	NULL
of	NULL
the	NULL
c-Rel	NULL
homodimer/DNA	NULL
complex	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
p50/c-Rel	NULL
heterodimer/DNA	NULL
complex	NULL
were	NULL
formed	NULL
with	NULL
an	NULL
IL-6	NULL
«	NULL
B	NULL
probe	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

These	NULL
results	NULL
were	NULL
also	NULL
confirmed	NULL
by	NULL
cross-competition	NULL
experiments	NULL
using	NULL
recombinant	NULL
p50	NULL
and	NULL
c-Rel	NULL
proteins	NULL
and	NULL
SV40	NULL
,	NULL
MHC	NULL
,	NULL
and	NULL
IL-6KB	NULL
sites	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
c-Rel	NULL
homodimer	NULL
appears	NULL
to	NULL
recognize	NULL
the	NULL
IL-6	NULL
«	NULL
B	NULL
motif	NULL
with	NULL
a	NULL
higher	NULL
affinity	NULL
than	NULL
does	NULL
the	NULL
p50/c-Rel	NULL
heterodimer	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
kB	NULL
motif	NULL
found	NULL
in	NULL
the	NULL
beta	NULL
interferon	NULL
promoter	NULL
(	NULL
IFB	NULL
,	NULL
GGGAAATTCC	NULL
)	NULL
(	NULL
39	NULL
)	NULL
was	NULL
also	NULL
found	NULL
to	NULL
have	NULL
a	NULL
higher	NULL
affinity	NULL
for	NULL
c-Rel	NULL
homodimers	NULL
than	NULL
for	NULL
p50	NULL
homodimers	NULL
or	NULL
pS50/c-Rel	NULL
heterodimers	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
pursue	NULL
this	NULL
issue	NULL
further	NULL
,	NULL
the	NULL
fixed	NULL
amount	NULL
of	NULL
p50	NULL
(	NULL
30	NULL
ng	NULL
)	NULL
and	NULL
increasing	NULL
amounts	NULL
of	NULL
c-Rel	NULL
(	NULL
400	NULL
to	NULL
1,000	NULL
ng	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
various	NULL
«	NULL
B	NULL
probes	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
c-Rel	NULL
homodimer/DNA	NULL
complexes	NULL
were	NULL
not	NULL
readily	NULL
visible	NULL
with	NULL
the	NULL
SV40xB	NULL
probe	NULL
even	NULL
at	NULL
the	NULL
input	NULL
of	NULL
1,000	NULL
ng	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
P50	NULL
P50	NULL
+	NULL
c-rel	NULL
c-rel	NULL
[	NULL
J	NULL
4	NULL
1	NULL
,	NULL
|	NULL
I	NULL
P	NULL
a50	NULL
aR	NULL
P	NULL
a50	NULL
aR	NULL
P	NULL
aso	NULL
aR	NULL
--	NULL
#	NULL
lase	NULL
Q	NULL
--	NULL
(	NULL
79kd	NULL
)	NULL
P50	NULL
(	NULL
63kd	NULL
)	NULL
-	NULL
»	NULL
wee	NULL
45kd	NULL
-	NULL
»	NULL
we	NULL
wee	NULL
<	NULL
-	NULL
43kd	NULL
1	NULL
P	NULL
Q	NULL
mek	NULL
-	NULL
7.	NULL
.	NULL

§	NULL
149	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Association	NULL
of	NULL
c-Rel	NULL
with	NULL
p50	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA-binding	NULL
sites	NULL
.	NULL

The	NULL
c-re/	NULL
and	NULL
p50	NULL
cDNAs	NULL
were	NULL
translated	NULL
alone	NULL
or	NULL
cotranslated	NULL
together	NULL
in	NULL
reticulocyte	NULL
lysates	NULL
that	NULL
contained	NULL
[	NULL
**SJme-thionine	NULL
.	NULL

The	NULL
in	NULL
vitro-translated	NULL
p50	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
,	NULL
p50	NULL
and	NULL
c-Rel	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
,	NULL
and	NULL
c-Rel	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
preimmune	NULL
sera	NULL
(	NULL
P	NULL
;	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
)	NULL
,	NULL
anti-p50	NULL
antisera	NULL
(	NULL
a50	NULL
;	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
)	NULL
,	NULL
or	NULL
anti-c-Rel	NULL
antisera	NULL
(	NULL
aR	NULL
;	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
analyzed	NULL
on	NULL
SDS-10	NULL
%	NULL
poly-acrylamide	NULL
gels	NULL
.	NULL

of	NULL
c-Rel	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
even	NULL
at	NULL
the	NULL
input	NULL
of	NULL
400	NULL
ng	NULL
of	NULL
c-Rel	NULL
,	NULL
significant	NULL
p50/c-Rel	NULL
heterodimer/DNA	NULL
complexes	NULL
were	NULL
not	NULL
seen	NULL
with	NULL
the	NULL
IL-6	NULL
«	NULL
B	NULL
probe	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

The	NULL
MHCKB	NULL
probe	NULL
appeared	NULL
to	NULL
have	NULL
comparable	NULL
affinities	NULL
for	NULL
the	NULL
p50/c-Rel	NULL
heterodimer	NULL
and	NULL
c-Rel	NULL
homodimer	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
results	NULL
of	NULL
these	NULL
experiments	NULL
indicate	NULL
that	NULL
the	NULL
c-Rel	NULL
homodimer	NULL
preferentially	NULL
binds	NULL
to	NULL
some	NULL
kB	NULL
motifs	NULL
such	NULL
as	NULL
IL-6	NULL
«	NULL
B	NULL
and	NULL
IFxB	NULL
.	NULL

We	NULL
also	NULL
examined	NULL
whether	NULL
p50	NULL
and	NULL
c-Rel	NULL
proteins	NULL
can	NULL
associate	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA-binding	NULL
sites	NULL
.	NULL

After	NULL
in	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
,	NULL
association	NULL
was	NULL
evaluated	NULL
by	NULL
coimmunoprecipitation	NULL
using	NULL
anti-p50	NULL
or	NULL
anti-c-Rel	NULL
antisera	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
p50	NULL
proteins	NULL
(	NULL
63	NULL
kDa	NULL
)	NULL
translated	NULL
in	NULL
vitro	NULL
were	NULL
specifically	NULL
recognized	NULL
by	NULL
anti-p50	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
but	NULL
not	NULL
by	NULL
anti-c-Rel	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
antisera	NULL
;	NULL
a	NULL
minor	NULL
component	NULL
(	NULL
45	NULL
kDa	NULL
)	NULL
which	NULL
was	NULL
also	NULL
recognized	NULL
by	NULL
anti-p50	NULL
antisera	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
is	NULL
probably	NULL
a	NULL
prematurely	NULL
terminated	NULL
product	NULL
.	NULL

Anti-c-Rel	NULL
antisera	NULL
also	NULL
specifically	NULL
reacted	NULL
with	NULL
in	NULL
vitro-translated	NULL
c-Rel	NULL
proteins	NULL
(	NULL
79	NULL
kDa	NULL
)	NULL
and	NULL
a	NULL
43-kDa	NULL
prematurely	NULL
terminated	NULL
product	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
antisera	NULL
prepared	NULL
against	NULL
recombinant	NULL
p50	NULL
and	NULL
c-Rel	NULL
proteins	NULL
were	NULL
specific	NULL
and	NULL
did	NULL
not	NULL
cross-react	NULL
each	NULL
other	NULL
despite	NULL
considerable	NULL
homology	NULL
in	NULL
their	NULL
N-terminal	NULL
portions	NULL
.	NULL

However	NULL
,	NULL
both	NULL
antisera	NULL
commu-noprecipitated	NULL
p50	NULL
and	NULL
c-Rel	NULL
proteins	NULL
from	NULL
the	NULL
reaction	NULL
mixture	NULL
containing	NULL
p50	NULL
and	NULL
c-Rel	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
indicating	NULL
the	NULL
formation	NULL
of	NULL
p50/c-Rel	NULL
heterodimers	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
.	NULL

Interestingly	NULL
,	NULL
anti-p50	NULL
antisera	NULL
coimmunoprecipitated	NULL
the	NULL
43-kDa	NULL
c-Rel	NULL
product	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
p50	NULL
and	NULL
anti-c-Rel	NULL
antisera	NULL
coimmunoprecipitated	NULL
the	NULL
45-kDa	NULL
p50	NULL
product	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
c-Rel	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
smaller	NULL
p50	NULL
or	NULL
c-Rel	NULL
proteins	NULL
can	NULL
heterodimerize	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
heterodimers	NULL
and	NULL
homodimers	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
was	NULL
also	NULL
confirmed	NULL
by	NULL
glutaraldehyde	NULL
cross-linking	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

INTERACTIONS	NULL
OF	NULL
c-Rel-RELATED	NULL
FACTORS	NULL
WITH	NULL
IL-6kB	NULL
1739	NULL
A	NULL
lymphoid	NULL
cell-specific	NULL
nuclear	NULL
factor	NULL
specifically	NULL
recognizing	NULL
IL-G6	NULL
«	NULL
B-related	NULL
motifs	NULL
contains	NULL
c-Rel	NULL
epitopes	NULL
.	NULL

Since	NULL
expression	NULL
of	NULL
the	NULL
c-re/	NULL
gene	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
much	NULL
higher	NULL
in	NULL
lymphoid	NULL
cells	NULL
than	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
(	NULL
10	NULL
,	NULL
12	NULL
)	NULL
and	NULL
since	NULL
the	NULL
c-Rel	NULL
homodimer	NULL
shows	NULL
a	NULL
high	NULL
affinity	NULL
for	NULL
the	NULL
IL-6	NULL
«	NULL
B	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
c-Rel	NULL
homodimers	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
lymphoid	NULL
cells	NULL
by	NULL
using	NULL
IL-6	NULL
«	NULL
B	NULL
probes	NULL
.	NULL

We	NULL
prepared	NULL
nuclear	NULL
extracts	NULL
from	NULL
various	NULL
lymphoid	NULL
and	NULL
nonlymphoid	NULL
cells	NULL
and	NULL
analyzed	NULL
them	NULL
by	NULL
EMSA	NULL
.	NULL

A	NULL
representative	NULL
EMSA	NULL
pattern	NULL
seen	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
helper	NULL
T	NULL
cells	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
.	NULL

As	NULL
shown	NULL
previously	NULL
(	NULL
45	NULL
,	NULL
54	NULL
)	NULL
,	NULL
stimulation	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
TNF-a	NULL
resulted	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
«	NULL
B-binding	NULL
factors	NULL
(	NULL
termed	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
which	NULL
had	NULL
the	NULL
mobility	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
HeLa-derived	NULL
NF-	NULL
«	NULL
B	NULL
;	NULL
the	NULL
results	NULL
of	NULL
epitope	NULL
analysis	NULL
indicated	NULL
that	NULL
Jurkat	NULL
NF-kB	NULL
is	NULL
mostly	NULL
a	NULL
p50/p65	NULL
heterodimer	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
;	NULL
Jurkat	NULL
NF-KB	NULL
recognized	NULL
IL-6	NULL
and	NULL
SV40	NULL
kB	NULL
motifs	NULL
with	NULL
comparable	NULL
affinities	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
.	NULL

The	NULL
IL-6kB	NULL
probe	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
formed	NULL
the	NULL
DNA/protein	NULL
complex	NULL
,	NULL
the	NULL
mobility	NULL
of	NULL
which	NULL
was	NULL
considerably	NULL
slower	NULL
than	NULL
those	NULL
of	NULL
nucleoprotein	NULL
complexes	NULL
mediated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
by	NULL
the	NULL
c-Rel	NULL
homodimer	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
factor	NULL
is	NULL
present	NULL
constitutively	NULL
and	NULL
tentatively	NULL
termed	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
.	NULL

Since	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
has	NULL
a	NULL
higher	NULL
affinity	NULL
for	NULL
multimerized	NULL
IL-6	NULL
«	NULL
B	NULL
sites	NULL
than	NULL
for	NULL
a	NULL
single	NULL
site	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
we	NULL
used	NULL
multimerized	NULL
(	NULL
three	NULL
copies	NULL
)	NULL
IL-6	NULL
«	NULL
kB	NULL
probes	NULL
in	NULL
the	NULL
subsequent	NULL
experiments	NULL
.	NULL

Figure	NULL
3B	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
competition	NULL
analysis	NULL
.	NULL

The	NULL
DNA/protein	NULL
complex	NULL
formed	NULL
by	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
and	NULL
IL-6kB	NULL
was	NULL
specifically	NULL
abolished	NULL
by	NULL
IL-6	NULL
«	NULL
B	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
and	NULL
IFB	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
but	NULL
not	NULL
significantly	NULL
by	NULL
SV40xB	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
MHCxB	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
IL-6	NULL
and	NULL
IFB	NULL
sequences	NULL
both	NULL
have	NULL
5-bp	NULL
AT-rich	NULL
sequences	NULL
in	NULL
the	NULL
middle	NULL
of	NULL
their	NULL
kB	NULL
motifs	NULL
,	NULL
but	NULL
has	NULL
a	NULL
cytosine	NULL
residue	NULL
in	NULL
these	NULL
AT-rich	NULL
sequences	NULL
.	NULL

We	NULL
therefore	NULL
constructed	NULL
several	NULL
mutants	NULL
of	NULL
the	NULL
SV40kB	NULL
motif	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
and	NULL
tested	NULL
them	NULL
in	NULL
competition	NULL
experiments	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
SV40kB	NULL
mutants	NULL
having	NULL
mutated	NULL
central	NULL
AT-rich	NULL
sequences	NULL
(	NULL
mt2	NULL
and	NULL
mt7	NULL
)	NULL
competed	NULL
for	NULL
IL-6kB	NULL
BFII-mediated	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
6	NULL
,	NULL
and	NULL
unpublished	NULL
data	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
central	NULL
AT-rich	NULL
sequences	NULL
are	NULL
important	NULL
for	NULL
the	NULL
interaction	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
with	NULL
DNA	NULL
.	NULL

We	NULL
also	NULL
analyzed	NULL
the	NULL
IL-6kB	NULL
BFII	NULL
activity	NULL
in	NULL
various	NULL
types	NULL
of	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
and	NULL
4	NULL
)	NULL
showed	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
is	NULL
specific	NULL
for	NULL
lymphoid	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
some	NULL
deviations	NULL
from	NULL
this	NULL
conclusion	NULL
were	NULL
noted	NULL
:	NULL
nuclear	NULL
extracts	NULL
from	NULL
several	NULL
human	NULL
(	NULL
KM-1	NULL
,	NULL
KM-2	NULL
,	NULL
and	NULL
AMO-1	NULL
)	NULL
and	NULL
mouse	NULL
(	NULL
MPC-11	NULL
)	NULL
myeloma	NULL
cell	NULL
lines	NULL
as	NULL
well	NULL
as	NULL
from	NULL
phagocytic	NULL
cell	NULL
lines	NULL
(	NULL
HL-60	NULL
and	NULL
U937	NULL
)	NULL
showed	NULL
reduced	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
results	NULL
that	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
recognizes	NULL
specifically	NULL
IL-6B	NULL
and	NULL
is	NULL
present	NULL
only	NULL
in	NULL
lymphoid	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
suggest	NULL
that	NULL
IL-6	NULL
«	NULL
kB	NULL
BFII	NULL
is	NULL
related	NULL
to	NULL
c-Rel	NULL
.	NULL

To	NULL
further	NULL
clarify	NULL
this	NULL
point	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
reactivity	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
with	NULL
anti-c-Rel	NULL
antisera	NULL
by	NULL
EMSA	NULL
.	NULL

As	NULL
expected	NULL
from	NULL
the	NULL
results	NULL
of	NULL
immunoprecipitation	NULL
analysis	NULL
with	NULL
anti-p50	NULL
and	NULL
anti-c-Rel	NULL
antisera	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
anti-p50	NULL
reacted	NULL
only	NULL
with	NULL
p50	NULL
and	NULL
supershifted	NULL
the	NULL
recombinant	NULL
p50	NULL
homodimer/DNA	NULL
complex	NULL
(	NULL
some	NULL
inhibition	NULL
of	NULL
p50	NULL
binding	NULL
to	NULL
DNA	NULL
was	NULL
also	NULL
observed	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
8	NULL
)	NULL
;	NULL
anti-c-Rel	NULL
antisera	NULL
specifically	NULL
supershifted	NULL
the	NULL
recombinant	NULL
c-Rel	NULL
homodimer/	NULL
DNA	NULL
complex	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
9	NULL
)	NULL
,	NULL
and	NULL
both	NULL
anti-c-Rel	NULL
and	NULL
anti-p50	NULL
antisera	NULL
supershifted	NULL
the	NULL
recombinant	NULL
p50/c-Rel	NULL
heterodimer/DNA	NULL
complexes	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
anti-p50	NULL
antisera	NULL
strongly	NULL
reacted	NULL
with	NULL
purified	NULL
HeLa	NULL
NF-kB	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
NF-	NULL
«	NULL
xB	NULL
from	NULL
IL-1-stimulated	NULL
Hep3B	NULL
cells	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
or	NULL
from	NULL
TNF-stimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

1740	NULL
NAKAYAMA	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bro..	NULL
probe	NULL
IL-6kB	NULL
_	NULL
SV40kB	NULL
6kE	NULL
/40kt	NULL
x1	NULL
I	NULL
~	NULL
e	NULL
JP	NULL
%	NULL
IL-6kB	NULL
b	NULL
4	NULL
___	NULL
L-6k8B	NULL
__	NULL
f	NULL
C	NULL
>	NULL
.	NULL

@	NULL
l	NULL
4	NULL
‘	NULL
QBFl*	NULL
“	NULL
“	NULL
..	NULL
sew	NULL
-*~*~	NULL
‘	NULL
ﬁ	NULL
‘	NULL
w.	NULL
’	NULL
be	NULL
ee	NULL
NF-KB	NULL
~-	NULL
NF-KB	NULL
-s	NULL
-	NULL
MB	NULL
NF-kB	NULL
-	NULL
»	NULL
ia	NULL
tnd	NULL
-	NULL
is	NULL
Qt	NULL
!	NULL

SV40kBwt	NULL
SV40kBmt4	NULL
V40kBmt	NULL
SV40kBmt	NULL
1	NULL
IL-6kB	NULL
FNKB	NULL
o	NULL
biwdhitihe	NULL
_	NULL
Glind	NULL
-=-	NULL
»	NULL
.	NULL

FIG	NULL
.	NULL

3	NULL
.	NULL

Detection	NULL
of	NULL
an	NULL
IL-6	NULL
«	NULL
B-specific	NULL
nuclear	NULL
factor	NULL
(	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
)	NULL
in	NULL
lymphoid	NULL
nuclear	NULL
extracts	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
of	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
(	NULL
C	NULL
)	NULL
and	NULL
TNF-stimulated	NULL
(	NULL
T	NULL
)	NULL
cells	NULL
with	NULL
IL-6	NULL
«	NULL
B	NULL
or	NULL
SV40	NULL
«	NULL
B	NULL
probes	NULL
(	NULL
x1	NULL
and	NULL
x3	NULL
indicate	NULL
probes	NULL
containing	NULL
one	NULL
and	NULL
three	NULL
copies	NULL
of	NULL
xB	NULL
motifs	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

DNA/protein	NULL
complexes	NULL
mediated	NULL
by	NULL
IL-6xB	NULL
BFII	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Competition	NULL
binding	NULL
analysis	NULL
.	NULL

The	NULL
IL-6	NULL
«	NULL
B	NULL
x3	NULL
probe	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
TNF-a-stimulated	NULL
Jurkat	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
following	NULL
fragments	NULL
(	NULL
100	NULL
ng	NULL
)	NULL
containing	NULL
various	NULL
multimerized	NULL
(	NULL
x3	NULL
)	NULL
«	NULL
B	NULL
sequences	NULL
were	NULL
used	NULL
in	NULL
competition	NULL
analysis	NULL
:	NULL
lane	NULL
1	NULL
,	NULL
none	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
wild-type	NULL
SV40xB	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
SV40xB	NULL
mt4	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
IL-6xB	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
IFxB	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
SV40	NULL
«	NULL
B	NULL
mt2	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
SV40	NULL
«	NULL
B	NULL
mtl	NULL
(	NULL
see	NULL
Table	NULL
1	NULL
for	NULL
sequences	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Analysis	NULL
of	NULL
IL-6xB	NULL
BFII	NULL
activity	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
lymphoid	NULL
and	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
various	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
by	NULL
using	NULL
multimerized	NULL
IL-6	NULL
«	NULL
B	NULL
probes	NULL
.	NULL

In	NULL
some	NULL
analyses	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
(	NULL
Cont	NULL
)	NULL
as	NULL
well	NULL
as	NULL
IL-1-	NULL
or	NULL
TNF-stimulated	NULL
cells	NULL
were	NULL
used	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
anti-c-Rel	NULL
antisera	NULL
barely	NULL
reacted	NULL
with	NULL
HeLa	NULL
or	NULL
function	NULL
as	NULL
a	NULL
potent	NULL
IL-1-TNF-responsive	NULL
promoter	NULL
element	NULL
Hep3B	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
and	NULL
showed	NULL
only	NULL
minimal	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
such	NULL
as	NULL
L-TK~	NULL
and	NULL
HeLa	NULL
cells	NULL
when	NULL
reactivity	NULL
with	NULL
Jurkat	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
epitope	NULL
inserted	NULL
upstream	NULL
of	NULL
TATA	NULL
elements	NULL
(	NULL
60	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
forego-analysis	NULL
on	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
with	NULL
these	NULL
antisera	NULL
are	NULL
shown	NULL
in	NULL
ing	NULL
results	NULL
show	NULL
that	NULL
a	NULL
c-Rel-related	NULL
factor	NULL
(	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
)	NULL
Fig	NULL
.	NULL

5C	NULL
.	NULL

Only	NULL
anti-c-Rel	NULL
antisera	NULL
blocked	NULL
significantly	NULL
(	NULL
60	NULL
to	NULL
specifically	NULL
recognizing	NULL
IL-6	NULL
«	NULL
B	NULL
is	NULL
present	NULL
in	NULL
lymphoid	NULL
cells	NULL
80	NULL
%	NULL
inhibition	NULL
)	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
IL-6	NULL
«	NULL
B	NULL
BFII/DNA	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
to	NULL
5	NULL
)	NULL
,	NULL
we	NULL
were	NULL
prompted	NULL
to	NULL
examine	NULL
the	NULL
in	NULL
vivo	NULL
complex	NULL
in	NULL
repeated	NULL
analyses	NULL
,	NULL
indicating	NULL
that	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
activity	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
series	NULL
of	NULL
CAT	NULL
contains	NULL
c-Rel	NULL
but	NULL
not	NULL
p50	NULL
epitopes	NULL
.	NULL

reporter	NULL
constructs	NULL
in	NULL
which	NULL
multimerized	NULL
(	NULL
three	NULL
copies	NULL
)	NULL
Differential	NULL
responsiveness	NULL
of	NULL
the	NULL
IL-6	NULL
«	NULL
B-related	NULL
motifs	NULL
to	NULL
SV40	NULL
,	NULL
MHC	NULL
,	NULL
and	NULL
IL-6	NULL
«	NULL
B	NULL
sequences	NULL
were	NULL
inserted	NULL
at	NULL
the	NULL
5	NULL
cytokines	NULL
and	NULL
HTLV-1	NULL
Tax	NULL
in	NULL
lymphoid	NULL
and	NULL
nonlymphoid	NULL
end	NULL
of	NULL
the	NULL
IL-6	NULL
TATA	NULL
element	NULL
were	NULL
transfected	NULL
into	NULL
either	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
IL-6	NULL
«	NULL
kB	NULL
motif	NULL
can	NULL
nonlymphoid	NULL
L-TK~	NULL
or	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
response	NULL
to	NULL
TABLE	NULL
1	NULL
.	NULL

Summary	NULL
of	NULL
sequence	NULL
comparison	NULL
and	NULL
of	NULL
DNA-binding	NULL
and	NULL
in	NULL
vivo	NULL
activities	NULL
of	NULL
various	NULL
kB	NULL
motifs	NULL
``	NULL
DNA	NULL
binding	NULL
In	NULL
vivo	NULL
response	NULL
«	NULL
B	NULL
motif	NULL
Sequence	NULL
s	NULL
c-Rel	NULL
``	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
NF-	NULL
«	NULL
B	NULL
L-TK~	NULL
Jurkat	NULL
SV40kB	NULL
Wild	NULL
type	NULL
TGGGGACTTTCCAC	NULL
+	NULL
-	NULL
++	NULL
++	NULL
++	NULL
mt4	NULL
TGGGGACTTTCCca	NULL
-	NULL
++	NULL
++	NULL
++	NULL
mt5	NULL
gaGGGACTTTCCAC	NULL
-	NULL
++	NULL
++	NULL
++	NULL
mtl	NULL
TGttGACTTTCCAC	NULL
-	NULL
-	NULL
-	NULL
-	NULL
mt3	NULL
TGGGGACTTTEZAC	NULL
-	NULL
-	NULL
-	NULL
mt6	NULL
TGGGatCTTTCCAC	NULL
-	NULL
-	NULL
-	NULL
mt2	NULL
TGGGGAtTTTCCAC	NULL
+	NULL
+	NULL
+	NULL
++	NULL
mt	NULL
?	NULL

TGGGGAgaTTCCAC	NULL
+	NULL
+	NULL
+	NULL
IL-6KkB	NULL
TGGGATTTTCCCA	NULL
+++	NULL
++	NULL
++	NULL
++	NULL
IFB	NULL
TGGGAAATTCCTC	NULL
+++	NULL
++	NULL
+	NULL
+	NULL
MHC	NULL
«	NULL
B	NULL
TGGGGATTCCCCA	NULL
+	NULL
+	NULL
++	NULL
++	NULL
++	NULL
Other	NULL
IL-6	NULL
«	NULL
B	NULL
related©	NULL
IL-18	NULL
(	NULL
15	NULL
)	NULL
GGGAAAATCC	NULL
IL-8	NULL
(	NULL
50	NULL
)	NULL
TGGAATTTCC	NULL
IP-10	NULL
(	NULL
46	NULL
)	NULL
GGGAAATTCC	NULL
``	NULL
The	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
and	NULL
unpublished	NULL
data	NULL
are	NULL
summarized	NULL
.	NULL

*	NULL
The	NULL
ability	NULL
of	NULL
each	NULL
sequence	NULL
to	NULL
bind	NULL
to	NULL
c-Rel	NULL
homodimers	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
pS0/c-Rel	NULL
heterodimers	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
is	NULL
indicated	NULL
by	NULL
+	NULL
to	NULL
+++	NULL
.	NULL

©	NULL
References	NULL
are	NULL
given	NULL
in	NULL
parentheses	NULL
.	NULL

Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
Relative	NULL
Activity	NULL
0	NULL
40	NULL
80	NULL
120	NULL
L-TK	NULL
``	NULL
NiH-3T3	NULL
Hela	NULL
Cos-1	NULL
Nonhemato-	NULL
FL	NULL
poietic	NULL
Cells	NULL
HepG2	NULL
T-24	NULL
Gs-1	NULL
SK-MG4	NULL
C6	NULL
-	NULL
NALM-16	NULL
70273	NULL
NALM-6	NULL
MANCA	NULL
NAMALVA	NULL
B	NULL
Cells	NULL
RAJ	NULL
BJAB	NULL
DAUDI	NULL
KM-1	NULL
Myeloma	NULL
KM-2	NULL
Cells	NULL
AMO-1	NULL
MPC-	NULL
11	NULL
Jurkat	NULL
MOLT-3	NULL
MOLT-4	NULL
CCRF-CEM	NULL
Phagocytic	NULL
E	NULL
HL-60	NULL
Cells	NULL
ug9a7	NULL
Nuit	NULL
Cells	NULL
Pre-B	NULL
Cels	NULL
[	NULL
_	NULL
T	NULL
Cells	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Summary	NULL
of	NULL
results	NULL
of	NULL
extensive	NULL
analyses	NULL
on	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
in	NULL
various	NULL
cells	NULL
.	NULL

IL-6	NULL
«	NULL
B	NULL
BFII	NULL
activities	NULL
were	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
which	NULL
was	NULL
set	NULL
at	NULL
a	NULL
value	NULL
of	NULL
100	NULL
.	NULL

B	NULL
A	NULL
PSO	NULL
+	NULL
PSO	NULL
C-rel	NULL
c-rel	NULL
§	NULL
~I	NULL
P	NULL
a50	NULL
aR	NULL
P	NULL
aS0	NULL
aR	NULL
P	NULL
aS0	NULL
aR	NULL
r*	NULL
(	NULL
1	NULL
w.	NULL
-_-	NULL
Ue	NULL
®	NULL
12090	NULL
Mig	NULL
-ne	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
INTERACTIONS	NULL
OF	NULL
c-Rel-RELATED	NULL
FACTORS	NULL
WITH	NULL
IL-6	NULL
«	NULL
B	NULL
1741	NULL
TNF-a	NULL
stimulation	NULL
or	NULL
to	NULL
cotransfection	NULL
of	NULL
the	NULL
HTLV-1	NULL
Tax	NULL
expression	NULL
vector	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
CAT	NULL
activ-ity	NULL
.	NULL

As	NULL
shown	NULL
previously	NULL
(	NULL
60	NULL
)	NULL
,	NULL
all	NULL
of	NULL
the	NULL
IL-6CAT	NULL
constructs	NULL
containing	NULL
IL-6	NULL
,	NULL
SV40	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
,	NULL
or	NULL
MHC	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
kB	NULL
sequences	NULL
showed	NULL
comparable	NULL
responses	NULL
to	NULL
TNF-a	NULL
and	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
or	NULL
to	NULL
IL-la	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
in	NULL
L-TK~	NULL
and	NULL
HeLa	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
however	NULL
,	NULL
while	NULL
the	NULL
CAT	NULL
reporter	NULL
genes	NULL
containing	NULL
SV40	NULL
or	NULL
MHC	NULL
«	NULL
B	NULL
motifs	NULL
responded	NULL
effectively	NULL
to	NULL
TNF-a	NULL
as	NULL
well	NULL
as	NULL
to	NULL
Tax	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
containing	NULL
IL-6	NULL
«	NULL
B	NULL
was	NULL
virtually	NULL
unresponsive	NULL
to	NULL
these	NULL
stimuli	NULL
in	NULL
Jurkat	NULL
cells	NULL
:	NULL
weak	NULL
but	NULL
significant	NULL
induction	NULL
by	NULL
Tax	NULL
of	NULL
the	NULL
IL-6	NULL
«	NULL
kB	NULL
CAT	NULL
reporter	NULL
gene	NULL
was	NULL
noted	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
sequence	NULL
specificities	NULL
involved	NULL
in	NULL
the	NULL
lymphoid	NULL
cell-specific	NULL
unresponsiveness	NULL
,	NULL
we	NULL
constructed	NULL
CAT	NULL
reporter	NULL
genes	NULL
containing	NULL
mutated	NULL
SV40xB	NULL
sequences	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
and	NULL
tested	NULL
these	NULL
constructs	NULL
for	NULL
their	NULL
in	NULL
vivo	NULL
responsiveness	NULL
to	NULL
TNF-a	NULL
in	NULL
L-TK~	NULL
and	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
;	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
)	NULL
showed	NULL
that	NULL
(	NULL
i	NULL
)	NULL
the	NULL
constructs	NULL
containing	NULL
mutated	NULL
SV40xB	NULL
sequences	NULL
which	NULL
are	NULL
defective	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
(	NULL
mtl	NULL
,	NULL
mt3	NULL
,	NULL
and	NULL
mt6	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
were	NULL
totally	NULL
inactive	NULL
both	NULL
in	NULL
L-TK~	NULL
and	NULL
Jurkat	NULL
cells	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
mt4	NULL
and	NULL
mt5	NULL
,	NULL
the	NULL
binding	NULL
specificities	NULL
of	NULL
which	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
the	NULL
wild-type	NULL
SV40xB	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
responded	NULL
to	NULL
TNF-a	NULL
in	NULL
both	NULL
L-TK~	NULL
and	NULL
Jurkat	NULL
cells	NULL
,	NULL
though	NULL
the	NULL
sequence	NULL
(	NULL
TGGGGACTTITTC	NULL
CCA	NULL
)	NULL
of	NULL
mt4	NULL
closely	NULL
resembles	NULL
of	NULL
that	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
(	NULL
TGG	NULL
GATTTTCCCA	NULL
)	NULL
;	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
the	NULL
mutants	NULL
having	NULL
substituted	NULL
middle	NULL
AT	NULL
-rich	NULL
sequences	NULL
(	NULL
mt2	NULL
and	NULL
mt7	NULL
)	NULL
recognized	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
6	NULL
)	NULL
and	NULL
responded	NULL
to	NULL
stimuli	NULL
in	NULL
L-TK~	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
in	NULL
vivo	NULL
unresponsiveness	NULL
of	NULL
several	NULL
kB	NULL
sequences	NULL
to	NULL
TNF-a	NULL
and	NULL
Tax	NULL
in	NULL
Jurkat	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
correlated	NULL
to	NULL
their	NULL
ability	NULL
to	NULL
bind	NULL
IL-6	NULL
«	NULL
B	NULL
BFIIL	NULL
.	NULL

C	NULL
Hela	NULL
Hep3B	NULL
Jurkat	NULL
P	NULL
a50	NULL
aR	NULL
P	NULL
a50	NULL
aR	NULL
P	NULL
a50	NULL
aR	NULL
P	NULL
_	NULL
a50	NULL
aR	NULL
aA	NULL
A	NULL
&	NULL
l	NULL
--	NULL
-H	NULL
Q	NULL
NF-kB	NULL
-	NULL
»	NULL
-	NULL
#	NULL
#	NULL
wo	NULL
-	NULL
bud	NULL
Hun	NULL
“	NULL
C	NULL
L.	NULL
v	NULL
#	NULL
%	NULL
s	NULL
%	NULL
1	NULL
2	NULL
3	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Presence	NULL
of	NULL
c-Rel	NULL
epitopes	NULL
in	NULL
IL-6xB	NULL
BFII	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Assay	NULL
in	NULL
which	NULL
the	NULL
nucleoprotein	NULL
complexes	NULL
mediated	NULL
by	NULL
recombinant	NULL
p50	NULL
homodimers	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
,	NULL
p50/c-Rel	NULL
heterodimers	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
,	NULL
and	NULL
c-Rel	NULL
homodimers	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
were	NULL
specifically	NULL
supershifted	NULL
by	NULL
anti-p50	NULL
(	NULL
a50	NULL
;	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
)	NULL
or	NULL
anti-c-Rel	NULL
(	NULL
aR	NULL
;	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
)	NULL
antisera	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
preimmune	NULL
sera	NULL
(	NULL
P	NULL
;	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
)	NULL
were	NULL
used	NULL
.	NULL

(	NULL
B	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
activities	NULL
from	NULL
various	NULL
sources	NULL
reacted	NULL
with	NULL
anti-p50	NULL
antisera	NULL
.	NULL

Either	NULL
partially	NULL
purified	NULL
HeLa	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
or	NULL
nuclear	NULL
extracts	NULL
from	NULL
IL-1-stimulated	NULL
Hep3B	NULL
cells	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
and	NULL
from	NULL
TNF-stimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
with	NULL
1	NULL
pl	NULL
of	NULL
preimmune	NULL
sera	NULL
,	NULL
anti-p50	NULL
antisera	NULL
,	NULL
or	NULL
anti-c-Rel	NULL
antisera	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
probes	NULL
.	NULL

The	NULL
SV40kB	NULL
(	NULL
x1	NULL
)	NULL
probe	NULL
was	NULL
used	NULL
in	NULL
the	NULL
experiments	NULL
shown	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Inhibition	NULL
of	NULL
IL-6xB	NULL
BFII	NULL
activity	NULL
by	NULL
anti-c-Rel	NULL
but	NULL
not	NULL
anti-p50	NULL
antisera	NULL
.	NULL

IL-6	NULL
«	NULL
B	NULL
BFII	NULL
partially	NULL
fractioned	NULL
from	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
was	NULL
incubated	NULL
with	NULL
1	NULL
pl	NULL
of	NULL
preimmune	NULL
sera	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
anti-p50	NULL
antisera	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
or	NULL
anti-c-Rel	NULL
antisera	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
(	NULL
x3	NULL
)	NULL
probes	NULL
.	NULL

Preimmune	NULL
sera	NULL
from	NULL
rabbits	NULL
immunized	NULL
with	NULL
c-Rel	NULL
or	NULL
p50	NULL
were	NULL
tested	NULL
,	NULL
and	NULL
the	NULL
results	NULL
for	NULL
preimmune	NULL
sera	NULL
from	NULL
the	NULL
rabbits	NULL
immunized	NULL
with	NULL
c-Rel	NULL
are	NULL
shown	NULL
.	NULL

1742	NULL
NAKAYAMA	NULL
ET	NULL
AL	NULL
.	NULL

(	NULL
___	NULL
tam	NULL
Relative	NULL
CAT	NULL
Activity	NULL
0	NULL
40	NULL
80	NULL
120	NULL
IL-6kBx3	NULL
(	NULL
TGGGATTTTCCCA	NULL
)	NULL
SV40kBx3	NULL
(	NULL
TGGGGACTTTCCAC	NULL
)	NULL
MHCKBx3	NULL
(	NULL
TGGGGATTCCCCA	NULL
)	NULL
IL-6kBmtx3	NULL
(	NULL
TTTGATTTTCCCA	NULL
)	NULL
SV40kBX3	NULL
(	NULL
TGGGGACTTTCCAC	NULL
)	NULL
IL-6kBx3	NULL
(	NULL
TGGGATTTTCCA	NULL
)	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Differential	NULL
responsiveness	NULL
of	NULL
the	NULL
IL-6	NULL
«	NULL
B	NULL
motif	NULL
to	NULL
TNF-	NULL
«	NULL
and	NULL
HTLV-1	NULL
Tax	NULL
in	NULL
Jurkat	NULL
(	NULL
A	NULL
)	NULL
and	NULL
L-TK~	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
.	NULL

After	NULL
transfection	NULL
of	NULL
various	NULL
reporter	NULL
genes	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
for	NULL
24	NULL
h	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
or	NULL
were	NULL
unstimulated	NULL
(	NULL
closed	NULL
bars	NULL
)	NULL
;	NULL
for	NULL
induction	NULL
by	NULL
Tax	NULL
(	NULL
shaded	NULL
bars	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
reporter	NULL
genes	NULL
and	NULL
Tax	NULL
expression	NULL
vectors	NULL
.	NULL

CAT	NULL
activities	NULL
are	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
CAT	NULL
activity	NULL
induced	NULL
by	NULL
TNF-a	NULL
from	NULL
CAT	NULL
reporter	NULL
genes	NULL
containing	NULL
SV40xB	NULL
,	NULL
which	NULL
was	NULL
set	NULL
at	NULL
a	NULL
value	NULL
of	NULL
100	NULL
.	NULL

DISCUSSION	NULL
The	NULL
results	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
show	NULL
that	NULL
the	NULL
c-re/	NULL
gene	NULL
product	NULL
binds	NULL
the	NULL
prototype	NULL
NF-	NULL
«	NULL
B-binding	NULL
motif	NULL
(	NULL
SV40kB	NULL
)	NULL
as	NULL
a	NULL
homodimer	NULL
as	NULL
well	NULL
as	NULL
a	NULL
heterodimer	NULL
with	NULL
p50	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Other	NULL
investigators	NULL
also	NULL
have	NULL
shown	NULL
recently	NULL
that	NULL
c-Rel	NULL
binds	NULL
MHCKB	NULL
motifs	NULL
as	NULL
homodimers	NULL
(	NULL
28	NULL
)	NULL
and	NULL
associates	NULL
with	NULL
p50	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
(	NULL
43	NULL
)	NULL
.	NULL

We	NULL
further	NULL
show	NULL
that	NULL
the	NULL
c-Rel	NULL
homodimer	NULL
and	NULL
p50/c-Rel	NULL
heterodimer	NULL
show	NULL
different	NULL
DNA-binding	NULL
specificities	NULL
and	NULL
affinities	NULL
for	NULL
SV40	NULL
,	NULL
MHC	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IF	NULL
«	NULL
B	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
IL-6	NULL
«	NULL
B	NULL
and	NULL
IFB	NULL
motifs	NULL
show	NULL
a	NULL
strong	NULL
affinity	NULL
for	NULL
the	NULL
c-Rel	NULL
homodimer	NULL
,	NULL
and	NULL
binding	NULL
of	NULL
the	NULL
p50/c-Rel	NULL
heterodimer	NULL
to	NULL
these	NULL
sites	NULL
is	NULL
inhibited	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
c-Rel	NULL
homodimer	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
the	NULL
SV40xB	NULL
motif	NULL
is	NULL
a	NULL
weak	NULL
binding	NULL
site	NULL
for	NULL
p50	NULL
and	NULL
c-Rel	NULL
homodimers	NULL
but	NULL
binds	NULL
effectively	NULL
to	NULL
the	NULL
p50/c-Rel	NULL
heterodimer	NULL
.	NULL

Although	NULL
the	NULL
p50	NULL
homodimer	NULL
shows	NULL
a	NULL
very	NULL
strong	NULL
affinity	NULL
for	NULL
MHCxB	NULL
,	NULL
the	NULL
extensive	NULL
binding	NULL
of	NULL
p50	NULL
homodimer	NULL
to	NULL
MHCkB	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
c-Rel	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
previous	NULL
studies	NULL
also	NULL
showed	NULL
that	NULL
the	NULL
p50	NULL
homodimer	NULL
and	NULL
p50/p65	NULL
heterodimer	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
have	NULL
distinct	NULL
DNA-binding	NULL
specificities	NULL
and	NULL
affinities	NULL
for	NULL
various	NULL
«	NULL
kB	NULL
motifs	NULL
(	NULL
63	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

L-TK~	NULL
cells	NULL
Jurkat	NULL
-	NULL
cells	NULL
wt	NULL
E	NULL
_	NULL
]	NULL
a7	NULL
_J	NULL
oz	NULL
mt	NULL
1	NULL
09	NULL
l	NULL
0.8	NULL
mt2	NULL
46	NULL
51	NULL
;	NULL
mt4	NULL
O	NULL
34	NULL
Jiao	NULL
mts	NULL
i	NULL
J	NULL
sz	NULL
J	NULL
ai	NULL
mt	NULL
?	NULL

F.	NULL
s	NULL
5	NULL
6	NULL
46	NULL
-	NULL
B0	NULL
-	NULL
120	NULL
40	NULL
~-	NULL
B0	NULL
-	NULL
120	NULL
Relative	NULL
CAT	NULL
Activity	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Responsiveness	NULL
of	NULL
various	NULL
SV40kB	NULL
mutants	NULL
to	NULL
TNF-a	NULL
in	NULL
Jurkat	NULL
and	NULL
L-TK~	NULL
cells	NULL
.	NULL

CAT	NULL
reporter	NULL
genes	NULL
containing	NULL
two	NULL
copies	NULL
of	NULL
various	NULL
SV40xB	NULL
mutant	NULL
sequences	NULL
(	NULL
see	NULL
Table	NULL
1	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
or	NULL
L-TK~	NULL
cells	NULL
.	NULL

The	NULL
degrees	NULL
of	NULL
TNF-a	NULL
activation	NULL
(	NULL
fold	NULL
induction	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
numbers	NULL
at	NULL
the	NULL
right	NULL
of	NULL
the	NULL
bars	NULL
.	NULL

association	NULL
of	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
in	NULL
various	NULL
combinations	NULL
theoretically	NULL
should	NULL
provide	NULL
the	NULL
complexes	NULL
with	NULL
diverse	NULL
but	NULL
distinct	NULL
DNA-binding	NULL
specificities	NULL
and	NULL
affinities	NULL
for	NULL
various	NULL
kB	NULL
motifs	NULL
and	NULL
possibly	NULL
with	NULL
different	NULL
transcriptional	NULL
activation	NULL
potentials	NULL
.	NULL

It	NULL
is	NULL
not	NULL
surprising	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
the	NULL
in	NULL
vivo	NULL
activities	NULL
of	NULL
various	NULL
xB	NULL
elements	NULL
are	NULL
differentially	NULL
regulated	NULL
in	NULL
different	NULL
types	NULL
of	NULL
cells	NULL
,	NULL
through	NULL
variations	NULL
in	NULL
relative	NULL
nuclear	NULL
levels	NULL
of	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
in	NULL
the	NULL
cells	NULL
.	NULL

One	NULL
of	NULL
the	NULL
surprising	NULL
findings	NULL
in	NULL
this	NULL
study	NULL
is	NULL
that	NULL
c-Rel	NULL
can	NULL
readily	NULL
associate	NULL
with	NULL
p50	NULL
without	NULL
combined	NULL
corenaturation	NULL
or	NULL
cotranslation	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
association	NULL
of	NULL
p50	NULL
with	NULL
p65	NULL
,	NULL
however	NULL
,	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
require	NULL
combined	NULL
corenaturation	NULL
or	NULL
cotranslation	NULL
(	NULL
5	NULL
,	NULL
53	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
clear	NULL
whether	NULL
the	NULL
failure	NULL
of	NULL
p65	NULL
to	NULL
associate	NULL
with	NULL
p50	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
corenaturation	NULL
or	NULL
cotranslation	NULL
is	NULL
due	NULL
to	NULL
an	NULL
intrinsic	NULL
property	NULL
of	NULL
p6S	NULL
or	NULL
incomplete	NULL
renaturation	NULL
.	NULL

However	NULL
,	NULL
given	NULL
the	NULL
observation	NULL
that	NULL
c-Rel	NULL
readily	NULL
associates	NULL
with	NULL
p50	NULL
and	NULL
the	NULL
fact	NULL
that	NULL
c-Rel	NULL
is	NULL
more	NULL
homologous	NULL
to	NULL
p65	NULL
than	NULL
to	NULL
p50	NULL
,	NULL
we	NULL
are	NULL
tempted	NULL
to	NULL
speculate	NULL
that	NULL
p65	NULL
also	NULL
readily	NULL
associates	NULL
with	NULL
p50	NULL
or	NULL
c-Rel	NULL
without	NULL
corenaturation	NULL
or	NULL
cotranslation	NULL
.	NULL

If	NULL
so	NULL
,	NULL
the	NULL
interactions	NULL
between	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
would	NULL
be	NULL
in	NULL
constant	NULL
equilibrium	NULL
in	NULL
vivo	NULL
and	NULL
would	NULL
be	NULL
modulated	NULL
by	NULL
relative	NULL
levels	NULL
of	NULL
these	NULL
proteins	NULL
,	NULL
which	NULL
may	NULL
be	NULL
regulated	NULL
by	NULL
cell-type-specific	NULL
mechanisms	NULL
as	NULL
well	NULL
as	NULL
by	NULL
extracellular	NULL
signals	NULL
such	NULL
as	NULL
cytokines	NULL
.	NULL

It	NULL
is	NULL
not	NULL
,	NULL
however	NULL
,	NULL
clear	NULL
at	NULL
present	NULL
whether	NULL
all	NULL
of	NULL
possible	NULL
homo-	NULL
or	NULL
het-erodimeric	NULL
complexes	NULL
of	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
are	NULL
physiologically	NULL
present	NULL
in	NULL
vivo	NULL
.	NULL

Our	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
as	NULL
well	NULL
as	NULL
those	NULL
of	NULL
others	NULL
show	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activities	NULL
from	NULL
HeLa	NULL
,	NULL
Jurkat	NULL
,	NULL
Hep3B	NULL
,	NULL
and	NULL
U937	NULL
cells	NULL
are	NULL
largely	NULL
the	NULL
complex	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
and	NULL
do	NULL
not	NULL
incorporate	NULL
a	NULL
significant	NULL
amount	NULL
of	NULL
c-Rel	NULL
proteins	NULL
(	NULL
1	NULL
,	NULL
57	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
Inoue	NULL
et	NULL
al	NULL
.	NULL

(	NULL
28	NULL
)	NULL
showed	NULL
that	NULL
c-Rel	NULL
is	NULL
a	NULL
part	NULL
of	NULL
NF-KB	NULL
activities	NULL
in	NULL
pre-B	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
show	NULL
in	NULL
this	NULL
study	NULL
that	NULL
the	NULL
lymphoid	NULL
cell-specific	NULL
nuclear	NULL
factor	NULL
IL-6kB	NULL
BFII	NULL
contains	NULL
c-Rel	NULL
but	NULL
not	NULL
p50	NULL
epitopes	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
there	NULL
appears	NULL
to	NULL
be	NULL
some	NULL
preference	NULL
in	NULL
the	NULL
interactions	NULL
between	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
in	NULL
different	NULL
types	NULL
of	NULL
cells	NULL
.	NULL

Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
As	NULL
discussed	NULL
above	NULL
,	NULL
the	NULL
association	NULL
of	NULL
c-Rel	NULL
with	NULL
p50	NULL
is	NULL
not	NULL
readily	NULL
detectable	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
vivo	NULL
,	NULL
through	NULL
c-Rel	NULL
proteins	NULL
are	NULL
generally	NULL
more	NULL
abundant	NULL
in	NULL
lymphoid	NULL
cells	NULL
(	NULL
10	NULL
,	NULL
12	NULL
)	NULL
and	NULL
can	NULL
readily	NULL
associate	NULL
with	NULL
p50	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
c-Rel	NULL
and	NULL
p50	NULL
form	NULL
discrete	NULL
complexes	NULL
in	NULL
vivo	NULL
.	NULL

By	NULL
using	NULL
IL-6	NULL
«	NULL
kB	NULL
probes	NULL
which	NULL
have	NULL
a	NULL
high	NULL
affinity	NULL
for	NULL
the	NULL
c-Rel	NULL
homodimer	NULL
,	NULL
we	NULL
found	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
lymphoid	NULL
cell-specific	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
(	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
)	NULL
that	NULL
specifically	NULL
recognizes	NULL
IL-6	NULL
«	NULL
B	NULL
and	NULL
some	NULL
other	NULL
related	NULL
«	NULL
B	NULL
motifs	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

IL-6	NULL
«	NULL
B	NULL
BFII	NULL
has	NULL
not	NULL
been	NULL
detected	NULL
previously	NULL
,	NULL
probably	NULL
because	NULL
of	NULL
the	NULL
lack	NULL
of	NULL
appropriate	NULL
probes	NULL
such	NULL
as	NULL
IL-6	NULL
«	NULL
kB	NULL
.	NULL

The	NULL
following	NULL
observations	NULL
indicate	NULL
that	NULL
IL-6kB	NULL
BFII	NULL
is	NULL
a	NULL
c-Rel-related	NULL
factor	NULL
.	NULL

First	NULL
,	NULL
and	NULL
most	NULL
important	NULL
,	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
IL-6kB	NULL
BFII	NULL
was	NULL
inhibited	NULL
by	NULL
anti-c-Rel	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Incomplete	NULL
inhibition	NULL
by	NULL
anti-c-Rel	NULL
antibodies	NULL
is	NULL
presumably	NULL
due	NULL
to	NULL
multiprotein	NULL
complex	NULL
formation	NULL
as	NULL
discussed	NULL
below	NULL
,	NULL
but	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
a	NULL
fraction	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
contains	NULL
c-Rel-like	NULL
factors	NULL
,	NULL
the	NULL
antigenicity	NULL
of	NULL
which	NULL
is	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
c-Rel	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
lack	NULL
of	NULL
reactivity	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
with	NULL
anti-p50	NULL
antisera	NULL
indicates	NULL
that	NULL
IL-6kB	NULL
BFII	NULL
does	NULL
not	NULL
contain	NULL
significant	NULL
amounts	NULL
of	NULL
p50	NULL
or	NULL
its	NULL
110-kDa	NULL
precursor	NULL
.	NULL

Second	NULL
,	NULL
IL-6	NULL
«	NULL
kB	NULL
BFII	NULL
and	NULL
c-Rel	NULL
homodimers	NULL
have	NULL
similar	NULL
DNA-binding	NULL
specificities	NULL
and	NULL
bind	NULL
preferentially	NULL
to	NULL
subsets	NULL
of	NULL
kB	NULL
motifs	NULL
such	NULL
as	NULL
IL-6	NULL
and	NULL
IF	NULL
«	NULL
B	NULL
motifs	NULL
which	NULL
have	NULL
5-bp	NULL
AT-rich	NULL
sequences	NULL
in	NULL
the	NULL
middle	NULL
of	NULL
binding	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
;	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
the	NULL
distributions	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
and	NULL
c-Rel	NULL
in	NULL
various	NULL
types	NULL
of	NULL
cells	NULL
are	NULL
strikingly	NULL
similar	NULL
:	NULL
their	NULL
expression	NULL
is	NULL
primarily	NULL
limited	NULL
to	NULL
lymphoid	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
(	NULL
10	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
however	NULL
,	NULL
both	NULL
IL-6kB	NULL
BFII	NULL
and	NULL
c-Rel	NULL
are	NULL
present	NULL
only	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
myeloma	NULL
and	NULL
phagocytic	NULL
cell	NULL
lines	NULL
;	NULL
MPC-11	NULL
cells	NULL
,	NULL
in	NULL
particular	NULL
,	NULL
show	NULL
only	NULL
a	NULL
trace	NULL
of	NULL
the	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
activity	NULL
and	NULL
c-re/	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
(	NULL
12	NULL
,	NULL
24	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
observations	NULL
indicate	NULL
that	NULL
c-Rel	NULL
homodimers	NULL
are	NULL
the	NULL
integral	NULL
part	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
is	NULL
the	NULL
c-Rel	NULL
homodimer	NULL
itself	NULL
,	NULL
since	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
nucleoprotein	NULL
complex	NULL
mediated	NULL
by	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
on	NULL
EMSA	NULL
is	NULL
considerably	NULL
slower	NULL
than	NULL
that	NULL
of	NULL
the	NULL
c-Rel/DNA	NULL
complex	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
size	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
estimated	NULL
by	NULL
gel	NULL
filtration	NULL
(	NULL
>	NULL
660	NULL
kDa	NULL
)	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
is	NULL
much	NULL
larger	NULL
than	NULL
the	NULL
estimated	NULL
size	NULL
of	NULL
the	NULL
c-Rel	NULL
homodimer	NULL
(	NULL
<	NULL
200	NULL
kDa	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
also	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
results	NULL
of	NULL
previous	NULL
studies	NULL
showing	NULL
that	NULL
the	NULL
c-Rel	NULL
protein	NULL
associates	NULL
with	NULL
other	NULL
cellular	NULL
proteins	NULL
in	NULL
avian	NULL
lymphoid	NULL
cells	NULL
(	NULL
16	NULL
,	NULL
36	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
two	NULL
different	NULL
c-Rel	NULL
complexes	NULL
have	NULL
been	NULL
identified	NULL
;	NULL
the	NULL
larger	NULL
complex	NULL
(	NULL
400	NULL
to	NULL
800	NULL
kDa	NULL
)	NULL
lacked	NULL
the	NULL
p34-40	NULL
protein	NULL
(	NULL
16	NULL
,	NULL
36	NULL
)	NULL
,	NULL
which	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
a	NULL
chicken	NULL
IxB	NULL
homolog	NULL
.	NULL

IxB	NULL
inhibits	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
is	NULL
thought	NULL
to	NULL
block	NULL
its	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
presumably	NULL
through	NULL
the	NULL
p65	NULL
subunit	NULL
(	NULL
5	NULL
)	NULL
.	NULL

IxB	NULL
likely	NULL
interacts	NULL
also	NULL
with	NULL
c-Rel	NULL
and	NULL
blocks	NULL
its	NULL
activity	NULL
,	NULL
since	NULL
c-Rel	NULL
is	NULL
more	NULL
homologous	NULL
to	NULL
p65	NULL
than	NULL
to	NULL
p50	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
postulate	NULL
that	NULL
while	NULL
a	NULL
major	NULL
part	NULL
of	NULL
c-Rel	NULL
synthesized	NULL
remains	NULL
in	NULL
the	NULL
cytoplasm	NULL
in	NULL
a	NULL
form	NULL
complexed	NULL
with	NULL
IB	NULL
,	NULL
a	NULL
portion	NULL
moves	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
associates	NULL
with	NULL
other	NULL
cellular	NULL
proteins	NULL
to	NULL
form	NULL
IL-6	NULL
«	NULL
kB	NULL
BFII	NULL
.	NULL

The	NULL
results	NULL
that	NULL
we	NULL
could	NULL
not	NULL
detect	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
activity	NULL
in	NULL
the	NULL
cytosol	NULL
fraction	NULL
and	NULL
that	NULL
IL-6kB	NULL
BFII	NULL
activity	NULL
is	NULL
sensitive	NULL
to	NULL
deoxycholate	NULL
{	NULL
unpublished	NULL
data	NULL
)	NULL
further	NULL
support	NULL
this	NULL
model	NULL
.	NULL

However	NULL
,	NULL
the	NULL
precise	NULL
subunit	NULL
composition	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
is	NULL
not	NULL
clear	NULL
at	NULL
present	NULL
.	NULL

Although	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
one	NULL
of	NULL
two	NULL
large	NULL
proteins	NULL
(	NULL
115	NULL
and	NULL
124	NULL
kDa	NULL
)	NULL
associated	NULL
with	NULL
c-Rel	NULL
corresponds	NULL
to	NULL
the	NULL
precursor	NULL
of	NULL
p50	NULL
(	NULL
21	NULL
)	NULL
,	NULL
our	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
do	NULL
not	NULL
support	NULL
this	NULL
possibility	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

(	NULL
8	NULL
)	NULL
have	NULL
recently	NULL
reported	NULL
a	NULL
novel	NULL
Rel-related	NULL
inducible	NULL
nuclear	NULL
factor	NULL
.	NULL

However	NULL
,	NULL
this	NULL
factor	NULL
appears	NULL
to	NULL
be	NULL
distinct	NULL
from	NULL
INTERACTIONS	NULL
OF	NULL
c-Rel-RELATED	NULL
FACTORS	NULL
WITH	NULL
IL-6	NULL
«	NULL
B	NULL
1743	NULL
A	NULL
NF-	NULL
B	NULL
Q	NULL
(	NULL
BF	NULL
11	NULL
)	NULL
p65	NULL
I1	NULL
-6	NULL
xB	NULL
c	NULL
rel	NULL
complex	NULL
cellular	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
+4	NULL
c-rel	NULL
complex	NULL
(	NULL
BF	NULL
41	NULL
)	NULL
SV-40	NULL
«	NULL
B	NULL
B	NULL
ur-xs	NULL
\	NULL
NF-	NULL
«	NULL
B	NULL
a	NULL
+1	NULL
1-6	NULL
«	NULL
B	NULL
NF-	NULL
xB	NULL
®	NULL
_..	NULL
sy	NULL
40	NULL
«	NULL
B	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Model	NULL
for	NULL
mechanisms	NULL
of	NULL
differential	NULL
regulation	NULL
by	NULL
IL-6B	NULL
BFII	NULL
(	NULL
c-Rel	NULL
complexes	NULL
)	NULL
in	NULL
IL-6	NULL
«	NULL
B-	NULL
and	NULL
transcriptional	NULL
activation	NULL
in	NULL
lymphoid	NULL
(	NULL
A	NULL
)	NULL
and	NULL
nonlymphoid	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
postulated	NULL
that	NULL
while	NULL
a	NULL
p50/p65	NULL
heterodimer	NULL
is	NULL
a	NULL
major	NULL
positive	NULL
transcriptional	NULL
factor	NULL
,	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
is	NULL
a	NULL
constitutive	NULL
IL-6	NULL
«	NULL
B	NULL
specific	NULL
repressor	NULL
.	NULL

IL-6	NULL
«	NULL
B	NULL
BFII	NULL
is	NULL
depicted	NULL
as	NULL
a	NULL
complex	NULL
in	NULL
which	NULL
c-Rel	NULL
homodimers	NULL
function	NULL
as	NULL
a	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
this	NULL
complex	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
higher	NULL
affinity	NULL
of	NULL
IL-6xB	NULL
BFII	NULL
for	NULL
IL-6	NULL
«	NULL
B	NULL
sites	NULL
,	NULL
NF-kB	NULL
can	NULL
not	NULL
displace	NULL
IL-6kB	NULL
BFII	NULL
from	NULL
IL-6xB	NULL
sites	NULL
and	NULL
can	NULL
not	NULL
activate	NULL
transcription	NULL
.	NULL

IL-6	NULL
«	NULL
B	NULL
BFII	NULL
,	NULL
since	NULL
IL-6kB	NULL
BFII	NULL
is	NULL
a	NULL
constitutive	NULL
factor	NULL
.	NULL

Further	NULL
work	NULL
is	NULL
required	NULL
to	NULL
establish	NULL
the	NULL
molecular	NULL
structure	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
IL-6	NULL
«	NULL
B	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
IL-1/TNF-responsive	NULL
element	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
(	NULL
60	NULL
)	NULL
.	NULL

However	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
the	NULL
present	NULL
study	NULL
,	NULL
IL-6kB	NULL
was	NULL
virtually	NULL
inactive	NULL
in	NULL
the	NULL
TNF	NULL
response	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
though	NULL
weak	NULL
and	NULL
significant	NULL
transactivation	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
CAT	NULL
reporter	NULL
genes	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

This	NULL
unresponsiveness	NULL
of	NULL
IL-6kB	NULL
in	NULL
Jurkat	NULL
cells	NULL
can	NULL
not	NULL
be	NULL
ascribed	NULL
to	NULL
a	NULL
lack	NULL
of	NULL
reactivity	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
with	NULL
Jurkat	NULL
NF-kB	NULL
,	NULL
since	NULL
IL-6	NULL
and	NULL
SV40	NULL
kB	NULL
sites	NULL
have	NULL
comparable	NULL
affinities	NULL
for	NULL
Jurkat	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
and	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
the	NULL
SV40kB	NULL
motif	NULL
revealed	NULL
that	NULL
the	NULL
SV40kB	NULL
mutants	NULL
(	NULL
mt2	NULL
and	NULL
mt7	NULL
)	NULL
containing	NULL
5-bp	NULL
AT-rich	NULL
sequences	NULL
bind	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
and	NULL
behave	NULL
like	NULL
IL-6xB	NULL
in	NULL
TNF	NULL
response	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
various	NULL
«	NULL
kB	NULL
sequences	NULL
to	NULL
bind	NULL
IL-6	NULL
«	NULL
kB	NULL
BFII	NULL
appears	NULL
to	NULL
be	NULL
correlated	NULL
to	NULL
their	NULL
unresponsiveness	NULL
to	NULL
TNF	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
as	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

Although	NULL
the	NULL
MHCxB	NULL
motif	NULL
shows	NULL
a	NULL
weak	NULL
affinity	NULL
for	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
but	NULL
functions	NULL
as	NULL
a	NULL
TNF-	NULL
and	NULL
Tax-responsive	NULL
element	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
this	NULL
result	NULL
is	NULL
explained	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
MHCKB	NULL
sites	NULL
have	NULL
a	NULL
much	NULL
higher	NULL
affinity	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

In	NULL
IL-6	NULL
«	NULL
B-related	NULL
sites	NULL
such	NULL
as	NULL
IL-6	NULL
«	NULL
kB	NULL
,	NULL
IFkB	NULL
,	NULL
SV40	NULL
mt2	NULL
,	NULL
and	NULL
SV40	NULL
mt7	NULL
,	NULL
however	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
could	NULL
not	NULL
displace	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
from	NULL
these	NULL
sites	NULL
because	NULL
of	NULL
the	NULL
higher	NULL
affinity	NULL
of	NULL
IL-6kB	NULL
BFII	NULL
for	NULL
these	NULL
sites	NULL
;	NULL
IL-6kB	NULL
BFII	NULL
thereby	NULL
could	NULL
suppress	NULL
the	NULL
NF-	NULL
«	NULL
B-mediated	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Although	NULL
our	NULL
model	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
1744	NULL
NAKAYAMA	NULL
ET	NULL
AL	NULL
.	NULL

postulates	NULL
that	NULL
the	NULL
c-Rel-related	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
functions	NULL
as	NULL
a	NULL
repressor	NULL
for	NULL
IL-6kB-related	NULL
motifs	NULL
,	NULL
others	NULL
have	NULL
shown	NULL
that	NULL
turkey	NULL
or	NULL
mouse	NULL
c-Rel	NULL
has	NULL
transcriptional	NULL
activation	NULL
domains	NULL
(	NULL
13	NULL
,	NULL
30	NULL
)	NULL
and	NULL
that	NULL
cotransfection	NULL
of	NULL
mouse	NULL
c-re/	NULL
expression	NULL
vectors	NULL
with	NULL
reporter	NULL
genes	NULL
containing	NULL
six	NULL
copies	NULL
of	NULL
MHC	NULL
«	NULL
B	NULL
sites	NULL
results	NULL
in	NULL
significant	NULL
transactivation	NULL
of	NULL
reporter	NULL
genes	NULL
in	NULL
nonlymphoid	NULL
F9	NULL
or	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Perhaps	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
c-Rel	NULL
would	NULL
be	NULL
differentially	NULL
regulated	NULL
in	NULL
different	NULL
types	NULL
of	NULL
cells	NULL
through	NULL
interaction	NULL
with	NULL
other	NULL
cellular	NULL
factors	NULL
as	NULL
discussed	NULL
above	NULL
.	NULL

The	NULL
dorsal	NULL
protein	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

family	NULL
(	NULL
29	NULL
,	NULL
62	NULL
)	NULL
,	NULL
and	NULL
v-Rel	NULL
,	NULL
the	NULL
viral	NULL
counterpart	NULL
of	NULL
c-Rel	NULL
(	NULL
8	NULL
,	NULL
18	NULL
,	NULL
28	NULL
)	NULL
,	NULL
can	NULL
indeed	NULL
function	NULL
both	NULL
as	NULL
positive	NULL
and	NULL
negative	NULL
regulators	NULL
.	NULL

There	NULL
are	NULL
also	NULL
other	NULL
examples	NULL
of	NULL
transcription	NULL
factors	NULL
with	NULL
dual	NULL
activities	NULL
(	NULL
14	NULL
,	NULL
22	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
despite	NULL
its	NULL
transcriptional	NULL
activating	NULL
potentials	NULL
,	NULL
c-Rel	NULL
may	NULL
also	NULL
function	NULL
as	NULL
a	NULL
negative	NULL
regulator	NULL
.	NULL

Although	NULL
IL-6	NULL
is	NULL
produced	NULL
by	NULL
diverse	NULL
types	NULL
of	NULL
cells	NULL
(	NULL
35	NULL
)	NULL
,	NULL
IL-6	NULL
production	NULL
by	NULL
normal	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
rare	NULL
(	NULL
31	NULL
,	NULL
65	NULL
)	NULL
.	NULL

However	NULL
,	NULL
aberrant	NULL
IL-6	NULL
production	NULL
in	NULL
several	NULL
malignant	NULL
cells	NULL
of	NULL
T-	NULL
or	NULL
B-cell	NULL
lineages	NULL
and	NULL
its	NULL
relationship	NULL
to	NULL
several	NULL
diseases	NULL
,	NULL
including	NULL
malignancy	NULL
,	NULL
have	NULL
been	NULL
reported	NULL
(	NULL
26	NULL
,	NULL
33	NULL
,	NULL
35	NULL
,	NULL
65	NULL
,	NULL
67	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
IL-6	NULL
has	NULL
been	NULL
purified	NULL
,	NULL
and	NULL
its	NULL
cDNA	NULL
has	NULL
been	NULL
cloned	NULL
from	NULL
HTLV-l-infected	NULL
T-cell	NULL
lines	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
while	NULL
the	NULL
IL-6	NULL
«	NULL
B	NULL
motif	NULL
is	NULL
virtually	NULL
unresponsive	NULL
to	NULL
TNF	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
results	NULL
in	NULL
a	NULL
significant	NULL
,	NULL
albeit	NULL
low	NULL
,	NULL
activation	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
reporter	NULL
genes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
an	NULL
IL-6	NULL
promoter/CAT	NULL
reporter	NULL
gene	NULL
having	NULL
a	NULL
defective	NULL
IL-6	NULL
«	NULL
B	NULL
site	NULL
is	NULL
unresponsive	NULL
to	NULL
Tax	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
aberrant	NULL
IL-6	NULL
production	NULL
by	NULL
HTLV-l-infected	NULL
T	NULL
cells	NULL
(	NULL
26	NULL
,	NULL
65	NULL
)	NULL
is	NULL
mediated	NULL
by	NULL
Tax	NULL
through	NULL
IL-6kB	NULL
as	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
a	NULL
gene	NULL
activation	NULL
by	NULL
Tax	NULL
,	NULL
which	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
IL-2	NULL
receptor	NULL
kB	NULL
motif	NULL
(	NULL
7	NULL
,	NULL
41	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
at	NULL
present	NULL
how	NULL
Tax	NULL
alleviates	NULL
the	NULL
repression	NULL
of	NULL
the	NULL
IL-6	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
though	NULL
TNF	NULL
and	NULL
Tax	NULL
are	NULL
apparently	NULL
equally	NULL
effective	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
7	NULL
,	NULL
41	NULL
,	NULL
45	NULL
,	NULL
54	NULL
)	NULL
.	NULL

One	NULL
provocative	NULL
possibility	NULL
is	NULL
that	NULL
Tax	NULL
directly	NULL
or	NULL
indirectly	NULL
modulates	NULL
the	NULL
formation	NULL
or	NULL
activity	NULL
of	NULL
IL-6	NULL
«	NULL
B	NULL
BFII	NULL
,	NULL
which	NULL
we	NULL
postulate	NULL
to	NULL
be	NULL
an	NULL
repressor	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
it	NULL
is	NULL
noteworthy	NULL
that	NULL
the	NULL
IL-1B	NULL
gene	NULL
,	NULL
which	NULL
is	NULL
not	NULL
expressed	NULL
normally	NULL
in	NULL
lymphoid	NULL
cells	NULL
but	NULL
is	NULL
aberrantly	NULL
expressed	NULL
in	NULL
HTLV-1-infected	NULL
T	NULL
cells	NULL
(	NULL
66	NULL
)	NULL
,	NULL
has	NULL
an	NULL
AT-rich	NULL
«	NULL
B	NULL
motif	NULL
(	NULL
15	NULL
)	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
similar	NULL
to	NULL
IL-6	NULL
«	NULL
kB	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
several	NULL
other	NULL
cytokine	NULL
genes	NULL
(	NULL
beta	NULL
interferon	NULL
,	NULL
IP-10	NULL
,	NULL
and	NULL
IL-8	NULL
genes	NULL
;	NULL
Table	NULL
1	NULL
)	NULL
also	NULL
have	NULL
IL-6	NULL
«	NULL
B-related	NULL
xB	NULL
motifs	NULL
in	NULL
their	NULL
promoters	NULL
(	NULL
39	NULL
,	NULL
46	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
cytokine	NULL
genes	NULL
,	NULL
including	NULL
the	NULL
IL-6	NULL
gene	NULL
,	NULL
may	NULL
be	NULL
under	NULL
similar	NULL
negative	NULL
control	NULL
mechanisms	NULL
through	NULL
IL-6kB-related	NULL
motifs	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
M.	NULL
Seiki	NULL
and	NULL
M.	NULL
Fujii	NULL
for	NULL
discussion	NULL
and	NULL
pHTLV-1	NULL
Tax	NULL
,	NULL
S.	NULL
Shimizu	NULL
for	NULL
human	NULL
myeloma	NULL
cell	NULL
lines	NULL
,	NULL
H.	NULL
Ito	NULL
for	NULL
recombinant	NULL
TNF-	NULL
«	NULL
,	NULL
M.	NULL
Nojiri	NULL
and	NULL
T.	NULL
Fujita	NULL
for	NULL
technical	NULL
assistance	NULL
,	NULL
and	NULL
K.	NULL
Take	NULL
for	NULL
typing	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Bachelerie	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1991	NULL
.	NULL

HIV	NULL
enhancer	NULL
activity	NULL
perpetuated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
on	NULL
infection	NULL
of	NULL
monocytes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
350:709-712	NULL
.	NULL

2	NULL
.	NULL

Baeverle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
activator	NULL
NF-kB	NULL
:	NULL
regulation	NULL
by	NULL
distinct	NULL
protein	NULL
subunit	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072:63-80	NULL
.	NULL

3	NULL
.	NULL

Baeverle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bro	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
§3:211-217.	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IxB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546.	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
65-kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
IxB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1689-1698.	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
P.	NULL
S.	NULL
Sharp	NULL
.	NULL

1988	NULL
.	NULL

Two	NULL
transcription	NULL
factors	NULL
,	NULL
NF-kB	NULL
and	NULL
H2TFL	NULL
,	NULL
interact	NULL
with	NULL
a	NULL
single	NULL
regulatory	NULL
sequence	NULL
in	NULL
the	NULL
class	NULL
I	NULL
major	NULL
histocompatibility	NULL
complex	NULL
pro-moter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:723-727.	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
Y.	NULL
Wano	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

HTLV-1	NULL
tax	NULL
cellular	NULL
proteins	NULL
that	NULL
activate	NULL
the	NULL
xB	NULL
element	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
a	NULL
gene	NULL
.	NULL

Science	NULL
241:1652-1655.	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
W.	NULL
H.	NULL
Walker	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
P.	NULL
Sista	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Molitor	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
M.	NULL
Hannink	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
v-rel/oncogene	NULL
encodes	NULL
a	NULL
kB	NULL
enhancer	NULL
binding	NULL
protein	NULL
that	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
function	NULL
.	NULL

Cell	NULL
53:803-814.	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
mitogen-inducible	NULL
gene	NULL
encoding	NULL
a	NULL
«	NULL
B	NULL
DNA-binding	NULL
protein	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
and	NULL
to	NULL
cell-cycle	NULL
motifs	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
348:76-80	NULL
.	NULL

Brownell	NULL
,	NULL
E.	NULL
,	NULL
B.	NULL
Mathieson	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
J.	NULL
Keller	NULL
,	NULL
J.	NULL
N.	NULL
Ihie	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1987	NULL
.	NULL

Detection	NULL
of	NULL
c-re/-related	NULL
transcripts	NULL
in	NULL
mouse	NULL
hematopoietic	NULL
tissues	NULL
,	NULL
fractionated	NULL
lymphocyte	NULL
popula-tions	NULL
,	NULL
and	NULL
cell	NULL
lines	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:1304-1309	NULL
.	NULL

Brownell	NULL
,	NULL
E.	NULL
,	NULL
N.	NULL
Mittereder	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
human	NULL
rel	NULL
proto-oncogene	NULL
cDNA	NULL
containing	NULL
an	NULL
Alu	NULL
fragment	NULL
as	NULL
a	NULL
potential	NULL
coding	NULL
exon	NULL
.	NULL

Oncogene	NULL
4:935-942	NULL
.	NULL

Brownell	NULL
,	NULL
E.	NULL
,	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
,	NULL
R.	NULL
G.	NULL
Smith	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1988	NULL
.	NULL

Detection	NULL
of	NULL
rel-related	NULL
RNA	NULL
and	NULL
protein	NULL
in	NULL
human	NULL
lymphoid	NULL
cells	NULL
.	NULL

Oncogene	NULL
3:93-98	NULL
.	NULL

Bull	NULL
,	NULL
P.	NULL
,	NULL
K.	NULL
L.	NULL
Morley	NULL
,	NULL
M.	NULL
F.	NULL
Hoekstra	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
mouse	NULL
c-Rel	NULL
protein	NULL
has	NULL
an	NULL
N-terminal	NULL
regulatory	NULL
domain	NULL
and	NULL
a	NULL
C-terminal	NULL
transcriptional	NULL
transactivation	NULL
domain	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:5473-5485	NULL
.	NULL

Chiu	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Angel	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1989	NULL
.	NULL

Jun-B	NULL
differs	NULL
in	NULL
its	NULL
biological	NULL
properties	NULL
from	NULL
,	NULL
and	NULL
is	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
c-Jun	NULL
.	NULL

Cell	NULL
59:979-986	NULL
.	NULL

Clark	NULL
,	NULL
B.	NULL
D.	NULL
,	NULL
K.	NULL
L.	NULL
Collins	NULL
,	NULL
M.	NULL
S.	NULL
Gandy	NULL
,	NULL
A.	NULL
C.	NULL
Webb	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Auron	NULL
.	NULL

1986	NULL
.	NULL

Genomic	NULL
sequence	NULL
for	NULL
human	NULL
prointerleukin	NULL
1	NULL
beta	NULL
:	NULL
possible	NULL
evolution	NULL
from	NULL
a	NULL
reverse	NULL
transcribed	NULL
prointerleukin	NULL
1	NULL
alpha	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:7877-7914	NULL
.	NULL

Davis	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
W.	NULL
Bargmann	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
Bose	NULL
,	NULL
Jr.	NULL
1990	NULL
.	NULL

Identification	NULL
of	NULL
protein	NULL
complexes	NULL
containing	NULL
the	NULL
c-rel	NULL
proto-oncogene	NULL
product	NULL
in	NULL
avian	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Oncogene	NULL
5:1109-1115	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

Gelinas	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
H.	NULL
M.	NULL
Temin	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
v-rel	NULL
oncogene	NULL
encodes	NULL
a	NULL
cell-specific	NULL
transcriptional	NULL
activator	NULL
of	NULL
certain	NULL
pro-moters	NULL
.	NULL

Oncogene	NULL
3:349-355	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
inhibitor	NULL
IxB	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344:678-682	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
M.	NULL
Gifford	NULL
,	NULL
L.	NULL
R.	NULL
Riviere	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
homology	NULL
to	NULL
rel	NULL
and	NULL
dorsal	NULL
.	NULL

Cell	NULL
62:1019-1029	NULL
.	NULL

Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
1990	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
,	NULL
KBF1	NULL
,	NULL
dorsal	NULL
,	NULL
and	NULL
related	NULL
matters	NULL
.	NULL

Cell	NULL
62:841-843	NULL
.	NULL

Glass	NULL
,	NULL
K.	NULL
G.	NULL
,	NULL
S.	NULL
M.	NULL
Liplin	NULL
,	NULL
O.	NULL
V.	NULL
Devary	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Rocenfeld	NULL
.	NULL

1989	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
gene	NULL
transcription	NULL
by	NULL
a	NULL
retinoic	NULL
acid-thyroid	NULL
hormone	NULL
receptor	NULL
heterodimer	NULL
.	NULL

Cell	NULL
59	NULL
:	NULL
679-708.	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
L.	NULL
F.	NULL
Moffat	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Howard	NULL
.	NULL

1982	NULL
.	NULL

Recombinant	NULL
genomes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyltransferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2:1044-1051	NULL
.	NULL

Grumont	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
S.	NULL
Gerondakis	NULL
,	NULL
1990	NULL
.	NULL

Murine	NULL
c-rel	NULL
transcription	NULL
is	NULL
rapidly	NULL
induced	NULL
in	NULL
T-cells	NULL
and	NULL
fibroblasts	NULL
by	NULL
mito-genic	NULL
agents	NULL
and	NULL
the	NULL
phorbol	NULL
ester	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

1:345-350	NULL
.	NULL

Hager	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
and	NULL
R.	NULL
R.	NULL
Burgess	NULL
.	NULL

1980	NULL
.	NULL

Elution	NULL
of	NULL
proteins	NULL
from	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43.	NULL
sodium	NULL
dodecy	NULL
}	NULL
sulfate-polyacrylamide	NULL
gels	NULL
,	NULL
removal	NULL
of	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
and	NULL
renaturation	NULL
of	NULL
enzymatic	NULL
activity	NULL
:	NULL
results	NULL
with	NULL
sigma	NULL
subunit	NULL
of	NULL
Escherichia	NULL
coli	NULL
RNA	NULL
polymerase	NULL
,	NULL
wheat	NULL
germ	NULL
DNA	NULL
topoisomerase	NULL
and	NULL
other	NULL
enzymes	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

109:76-86	NULL
.	NULL

Hirano	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Yasukawa	NULL
,	NULL
H.	NULL
Harada	NULL
,	NULL
T.	NULL
Taga	NULL
,	NULL
Y.	NULL
Watanabe	NULL
,	NULL
T.	NULL
Matsuda	NULL
,	NULL
S.	NULL
Kashiwamura	NULL
,	NULL
K.	NULL
Nakajiama	NULL
,	NULL
K.	NULL
Koyama	NULL
,	NULL
A.	NULL
Iwamatsu	NULL
,	NULL
S.	NULL
Tsunasawa	NULL
,	NULL
F.	NULL
Sakiyama	NULL
,	NULL
H.	NULL
Matsui	NULL
,	NULL
Y.	NULL
Takahara	NULL
,	NULL
T.	NULL
Taniguchi	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1986	NULL
.	NULL

Complementary	NULL
DNA	NULL
for	NULL
a	NULL
novel	NULL
human	NULL
interleukin	NULL
(	NULL
BSF-2	NULL
)	NULL
that	NULL
induces	NULL
B	NULL
lymphocytes	NULL
to	NULL
produce	NULL
immunoglobulin	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
324:73-76	NULL
.	NULL

Hohmann	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
Kolbeck	NULL
,	NULL
R.	NULL
Remy	NULL
,	NULL
and	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
Van	NULL
Loon	NULL
.	NULL

1991	NULL
.	NULL

Cyclic	NULL
AMP-independent	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
HL-60	NULL
cells	NULL
by	NULL
tumor	NULL
necrosis	NULL
factors	NULL
a	NULL
and	NULL
B.	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:2315-2318	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
D.	NULL
Kerr	NULL
,	NULL
L.	NULL
J.	NULL
Ransone	NULL
,	NULL
E.	NULL
Bengal	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1991.	NULL
c-rel	NULL
activates	NULL
but	NULL
v-rel	NULL
suppresses	NULL
transcription	NULL
from	NULL
xB	NULL
sites	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:3715-3719	NULL
.	NULL

Ip	NULL
,	NULL
Y.	NULL
T.	NULL
,	NULL
R.	NULL
Krout	NULL
,	NULL
M.	NULL
Levine	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rushlow	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
dorsal	NULL
morphogen	NULL
is	NULL
a	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
protein	NULL
that	NULL
interacts	NULL
with	NULL
a	NULL
long-range	NULL
repression	NULL
element	NULL
in	NULL
Dro-sophila	NULL
.	NULL

Cell	NULL
64:439-446	NULL
.	NULL

Kamens	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
Richardson	NULL
,	NULL
G.	NULL
Mosialos	NULL
,	NULL
R.	NULL
Brent	NULL
,	NULL
and	NULL
T.	NULL
Gilmore	NULL
.	NULL

1990	NULL
.	NULL

Oncogene	NULL
transformation	NULL
by	NULL
v-re/	NULL
requires	NULL
an	NULL
amino-terminal	NULL
activation	NULL
domain	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:2840-2847	NULL
.	NULL

Kato	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Yokoi	NULL
,	NULL
N.	NULL
Takano	NULL
,	NULL
H.	NULL
Kanegane	NULL
,	NULL
A.	NULL
Yachie	NULL
,	NULL
T.	NULL
Miyawaki	NULL
,	NULL
and	NULL
N.	NULL
Taniguchi	NULL
.	NULL

1990	NULL
.	NULL

Detection	NULL
by	NULL
in	NULL
situ	NULL
hybrid-ization	NULL
and	NULL
phenotypic	NULL
characterization	NULL
of	NULL
cells	NULL
expressing	NULL
IL-6	NULL
mRNA	NULL
in	NULL
human	NULL
stimulated	NULL
blood	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:1317-1322	NULL
.	NULL

Kawakami	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Scheidereit	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
and	NULL
purification	NULL
of	NULL
a	NULL
human	NULL
immunoglobulin-enhancer-binding	NULL
protein	NULL
(	NULL
NF-xB	NULL
)	NULL
that	NULL
transactivates	NULL
transcription	NULL
from	NULL
a	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
I	NULL
promoter	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:4700-4704	NULL
.	NULL

Kawano	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
T.	NULL
Matsuda	NULL
,	NULL
T.	NULL
Taga	NULL
,	NULL
Y.	NULL
Horii	NULL
,	NULL
K.	NULL
Iwato	NULL
,	NULL
H.	NULL
Asaoku	NULL
,	NULL
B.	NULL
Tang	NULL
,	NULL
O.	NULL
Tanabe	NULL
,	NULL
H.	NULL
Tanaka	NULL
,	NULL
A.	NULL
Kuramoto	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1988	NULL
.	NULL

Autocrine	NULL
generation	NULL
and	NULL
requirement	NULL
of	NULL
BSF-2/IL-6	NULL
for	NULL
human	NULL
multiple	NULL
myelomas	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
332:83-85	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vandekerckhove	NULL
,	NULL
F.	NULL
Lott-speich	NULL
,	NULL
O.	NULL
L.	NULL
Bail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1l	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

Kishimoto	NULL
,	NULL
T.	NULL
1989	NULL
.	NULL

The	NULL
biology	NULL
of	NULL
interleukin-6	NULL
.	NULL

Blood	NULL
74:1-10	NULL
.	NULL

Kochel	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
F.	NULL
Mushinski	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
v-rel	NULL
and	NULL
c-rel	NULL
proteins	NULL
exist	NULL
in	NULL
high	NULL
molecular	NULL
weight	NULL
complexes	NULL
in	NULL
avian	NULL
and	NULL
murine	NULL
cells	NULL
.	NULL

Oncogene	NULL
6:615-626	NULL
.	NULL

Lee	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
X.	NULL
Wu	NULL
,	NULL
R.	NULL
A.	NULL
Gibbs	NULL
,	NULL
R.	NULL
G.	NULL
Cook	NULL
,	NULL
D.	NULL
M.	NULL
Muzny	NULL
,	NULL
and	NULL
L.	NULL
T.	NULL
Caskey	NULL
.	NULL

1988	NULL
.	NULL

Generation	NULL
of	NULL
cDNA	NULL
probes	NULL
directed	NULL
by	NULL
amino	NULL
acid	NULL
sequence	NULL
:	NULL
cloning	NULL
of	NULL
urate	NULL
oxidase	NULL
.	NULL

Science	NULL
239	NULL
:	NULL
1288-1291	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

NF-kB	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58:227-229	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
C.	NULL
M.	NULL
Fan	NULL
,	NULL
T.	NULL
Maniatis	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
B-interferon	NULL
gene	NULL
regulation	NULL
reveals	NULL
its	NULL
role	NULL
as	NULL
widely	NULL
inducible	NULL
mediator	NULL
of	NULL
signal	NULL
transduc-tion	NULL
.	NULL

Cell	NULL
57:287-294	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
L.	NULL
Staudt	NULL
,	NULL
P.	NULL
Robbins	NULL
,	NULL
A.	NULL
Kuang	NULL
,	NULL
R.	NULL
C.	NULL
Mulligan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

Repression	NULL
of	NULL
the	NULL
IgH	NULL
enhancer	NULL
in	NULL
teratocarcinoma	NULL
cells	NULL
associated	NULL
with	NULL
a	NULL
novel	NULL
octamer	NULL
factor	NULL
.	NULL

Science	NULL
243:544-546	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1988	NULL
.	NULL

HTLV-1	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
333:776-778	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
interleukin-6	NULL
gene	NULL
expression	NULL
through	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:2327-2334	NULL
.	NULL

Logeat	NULL
,	NULL
F.	NULL
,	NULL
N.	NULL
Israél	NULL
,	NULL
R.	NULL
Ten	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
O.	NULL
L.	NULL
Bail	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
,	NULL
1991	NULL
.	NULL

Inhibition	NULL
of	NULL
transcription	NULL
factors	NULL
belonging	NULL
to	NULL
the	NULL
rel/NF-	NULL
«	NULL
B	NULL
family	NULL
by	NULL
a	NULL
transdominant	NULL
negative	NULL
mutant	NULL
.	NULL

INTERACTIONS	NULL
OF	NULL
c-Rel-RELATED	NULL
FACTORS	NULL
WITH	NULL
IL-6kB	NULL
45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

S1	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

1745	NULL
EMBO	NULL
J	NULL
.	NULL

10:1827-1832.	NULL
.	NULL

Lopata	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
D.	NULL
W.	NULL
Cleveland	NULL
,	NULL
and	NULL
B.	NULL
Sollner-Webb	NULL
.	NULL

1984	NULL
.	NULL

High	NULL
level	NULL
transient	NULL
expression	NULL
of	NULL
a	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
gene	NULL
by	NULL
DEAE-dextran	NULL
mediated	NULL
DNA	NULL
transfection	NULL
coupled	NULL
with	NULL
a	NULL
dimethyl	NULL
sulfoxide	NULL
or	NULL
glycerol	NULL
shock	NULL
treatment	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12:5707-5717	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
induces	NULL
proteins	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
kB-like	NULL
enhancer	NULL
elements	NULL
and	NULL
regulate	NULL
interleukin	NULL
2	NULL
receptor	NULL
«	NULL
-chain	NULL
gene	NULL
expression	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2231-2235	NULL
.	NULL

Luster	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
and	NULL
J.	NULL
V.	NULL
Ravetch	NULL
.	NULL

1987	NULL
.	NULL

Genomic	NULL
characterization	NULL
of	NULL
a	NULL
gamma-interferon-inducible	NULL
gene	NULL
(	NULL
IP-10	NULL
)	NULL
and	NULL
identification	NULL
of	NULL
an	NULL
interferon-inducible	NULL
hypersensitive	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:3723-3731	NULL
.	NULL

Mayer	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
H.	NULL
Hatada	NULL
,	NULL
H.	NULL
P.	NULL
Hohmann	NULL
,	NULL
M.	NULL
Haiker	NULL
,	NULL
C.	NULL
Bartsch	NULL
,	NULL
U.	NULL
Rothlisberger	NULL
,	NULL
H.	NULL
W.	NULL
Lahm	NULL
,	NULL
E.	NULL
J.	NULL
Schlaeger	NULL
,	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
Van	NULL
Loon	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
human	NULL
nuclear	NULL
factor	NULL
xB	NULL
:	NULL
the	NULL
level	NULL
of	NULL
its	NULL
mRNA	NULL
is	NULL
strongly	NULL
regulated	NULL
by	NULL
phorbol	NULL
ester	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:966-970	NULL
.	NULL

Meichle	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
S.	NULL
Schiitze	NULL
,	NULL
G.	NULL
Hensel	NULL
,	NULL
D.	NULL
Brunsing	NULL
,	NULL
and	NULL
M.	NULL
Kronke	NULL
.	NULL

1990	NULL
.	NULL

Protein	NULL
kinase	NULL
C-independent	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
kB	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:8339-8343	NULL
.	NULL

Morrison	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
N.	NULL
Kabrun	NULL
,	NULL
S.	NULL
Mudri	NULL
,	NULL
M.	NULL
J.	NULL
Hayman	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Enrietto	NULL
.	NULL

1989	NULL
.	NULL

Viral	NULL
rel	NULL
and	NULL
cellular	NULL
rel	NULL
associate	NULL
with	NULL
cellular	NULL
proteins	NULL
in	NULL
transformed	NULL
and	NULL
normal	NULL
cells	NULL
.	NULL

Oncogene	NULL
4:677-683	NULL
.	NULL

Mukaida	NULL
,	NULL
N.	NULL
,	NULL
M.	NULL
Shiroo	NULL
,	NULL
and	NULL
K.	NULL
Matsushima	NULL
.	NULL

1989	NULL
.	NULL

Genomic	NULL
structure	NULL
of	NULL
the	NULL
human	NULL
monocyte-derived	NULL
neutrophil	NULL
chemotac-tic	NULL
factor	NULL
IL-8	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:1366-1371	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
S.	NULL
McCam	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
new	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
motif	NULL
in	NULL
immunoglobulin	NULL
enhancer	NULL
binding	NULL
,	NULL
daughterless	NULL
MyoD	NULL
,	NULL
and	NULL
myc	NULL
proteins	NULL
.	NULL

Cell	NULL
56:777-783	NULL
.	NULL

Nerenberg	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Hinrichs	NULL
,	NULL
R.	NULL
K.	NULL
Reynolds	NULL
,	NULL
G.	NULL
Khoury	NULL
,	NULL
and	NULL
G.	NULL
Jay	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
tat	NULL
gene	NULL
of	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
induces	NULL
mesenchymal	NULL
tumors	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Science	NULL
237	NULL
:	NULL
1324-1329	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
H.	NULL
C.	NULL
Liou	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
binding	NULL
and	NULL
IxB	NULL
inhibition	NULL
of	NULL
the	NULL
cloned	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
a	NULL
rel-related	NULL
polypeptide	NULL
.	NULL

Cell	NULL
64:961-969	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2336-2340	NULL
.	NULL

Rosenberg	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
B.	NULL
N.	NULL
Labe	NULL
,	NULL
D.	NULL
Chui	NULL
,	NULL
S.	NULL
Lin	NULL
,	NULL
J.	NULL
J.	NULL
Dunn	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Studier	NULL
.	NULL

1987	NULL
.	NULL

Vectors	NULL
for	NULL
selective	NULL
expression	NULL
of	NULL
cloned	NULL
DNAs	NULL
by	NULL
T7	NULL
RNA	NULL
polymerase	NULL
.	NULL

Gene	NULL
56:125-135	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Scherck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.	NULL
H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerie	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
rel-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
251:1490-1493	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Rieber	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1991	NULL
.	NULL

Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
apparently	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
and	NULL
HIV-1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:2247-2258	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

Multiple	NULL
nuclear	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
sequences	NULL
.	NULL

Cell	NULL
46:705-716	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

Inducibility	NULL
of	NULL
k	NULL
immunoglobulin	NULL
enhancer-binding	NULL
protein	NULL
NF-kB	NULL
by	NULL
a	NULL
posttranslational	NULL
mechanism	NULL
.	NULL

Cell	NULL
47:921-928	NULL
.	NULL

Shimizu	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Mitomo	NULL
,	NULL
T.	NULL
Watanabe	NULL
,	NULL
S.	NULL
Okamoto	NULL
,	NULL
and	NULL
K.	NULL
Yamamoto	NULL
.	NULL

1990	NULL
.	NULL

Involvement	NULL
of	NULL
a	NULL
NF-	NULL
«	NULL
B-like	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
interleukin-6	NULL
gene	NULL
by	NULL
inflammatory	NULL
lymphokines	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:561-568	NULL
.	NULL

Shirakawa	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
S.	NULL
B.	NULL
Mizel	NULL
.	NULL

1989	NULL
.	NULL

In	NULL
vitro	NULL
activation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
catalyzed	NULL
by	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
and	NULL
protein	NULL
kinase	NULL
C.	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:2424-2430	NULL
.	NULL

Thisse	NULL
,	NULL
C.	NULL
,	NULL
F.	NULL
Perrin-Schmitt	NULL
,	NULL
C.	NULL
Stoetzel	NULL
,	NULL
and	NULL
B.	NULL
Thisse	NULL
.	NULL

1991	NULL
.	NULL

Sequence	NULL
specific	NULL
transactivation	NULL
of	NULL
the	NULL
Drosophila	NULL
twist	NULL
gene	NULL
1746	NULL
63	NULL
.	NULL

65	NULL
.	NULL

NAKAYAMA	NULL
ET	NULL
AL	NULL
.	NULL

by	NULL
the	NULL
dorsal	NULL
product	NULL
.	NULL

Cell	NULL
65:1191-1201	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerie	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
receptor	NULL
for	NULL
IxB	NULL
and	NULL
a	NULL
modulator	NULL
of	NULL
DNA-binding	NULL
specificity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1975-1984.	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

NF-B	NULL
contacts	NULL
DNA	NULL
by	NULL
a	NULL
heterodimer	NULL
of	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunit	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:1817-1825	NULL
.	NULL

Villiger	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
M.	NULL
T.	NULL
Cronin	NULL
,	NULL
T.	NULL
Amenomori	NULL
,	NULL
W.	NULL
Wachsman	NULL
,	NULL
and	NULL
M.	NULL
Lots	NULL
.	NULL

1991	NULL
.	NULL

IL-6	NULL
production	NULL
by	NULL
human	NULL
T	NULL
lymphocytes	NULL
expression	NULL
in	NULL
HTLV-l-infected	NULL
but	NULL
not	NULL
in	NULL
normal	NULL
T	NULL
cell	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:550-559	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bor	NULL
.	NULL

Wano	NULL
,	NULL
Y.	NULL
,	NULL
T.	NULL
Hattori	NULL
,	NULL
M.	NULL
Matsuoka	NULL
,	NULL
M.	NULL
Takatsuki	NULL
,	NULL
A.	NULL
O.	NULL
Chua	NULL
,	NULL
U.	NULL
Gubler	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1987	NULL
.	NULL

Interleukin	NULL
1	NULL
gene	NULL
expression	NULL
in	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

80:911-~916	NULL
.	NULL

Yokoi	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Miyawaki	NULL
,	NULL
A.	NULL
Yachie	NULL
,	NULL
K.	NULL
Kato	NULL
,	NULL
Y.	NULL
Kasahara	NULL
,	NULL
and	NULL
N.	NULL
Taniguchi	NULL
.	NULL

1990	NULL
.	NULL

Epstein-Barr	NULL
virus-immortalized	NULL
B	NULL
cells	NULL
produce	NULL
IL-6	NULL
as	NULL
an	NULL
autocrine	NULL
growth	NULL
factor	NULL
.	NULL

Immunology	NULL
70	NULL
:	NULL
100-105	NULL
.	NULL

Zhang	NULL
,	NULL
Y.	NULL
,	NULL
J.-X	NULL
.	NULL

Lin	NULL
,	NULL
and	NULL
J.	NULL
Vilcek	NULL
.	NULL

1990	NULL
.	NULL

Interleukin-6	NULL
induction	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
in	NULL
human	NULL
fibroblasts	NULL
involves	NULL
activation	NULL
of	NULL
a	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
a	NULL
xB-like	NULL
sequence	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:3818-3823	NULL
.	NULL

